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Summary
Inferring tumour evolution from single-cell and
multi-sample data
Edith M. Ross
Tumour development has long been recognised as an evolutionary process during which
cells accumulate mutations and evolve into a mix of genetically distinct cell subpopulations.
The resulting genetic intra-tumour heterogeneity poses a major challenge to cancer therapy,
as it increases the chance of drug resistance. To study tumour evolution in more detail,
reliable approaches to infer the life histories of tumours are needed. This dissertation focuses
on computational methods for inferring trees of tumour evolution from single-cell and
multi-sample sequencing data.
Recent advances in single-cell sequencing technologies have promised to reveal tumour
heterogeneity at a much higher resolution, but single-cell sequencing data is inherently noisy,
making it unsuitable for analysis with classic phylogenetic methods. The first part of the
dissertation describes OncoNEM, a novel probabilistic method to infer clonal lineage trees
from noisy single nucleotide variants of single cells. Simulation studies are used to validate
the method and to compare its performance to that of other methods. Finally, OncoNEM is
applied in two case studies.
In the second part of the dissertation, a comprehensive collection of existing multi-
sample approaches is used to infer the phylogenies of metastatic breast cancers from ten
patients. In particular, shallow whole-genome, whole exome and targeted deep sequencing
data are analysed. The inference methods comprise copy number and point mutation based
approaches, as well as a method that utilises a combination of the two. To improve the
copy number based inference, a novel allele-specific multi-sample segmentation algorithm is
presented. The results are compared across methods and data types to assess the reliability of
the different methods.
In summary, this thesis presents substantial methodological advances to understand
tumour evolution from genomic profiles of single cells or related bulk samples.
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Chapter 1
Introduction
This thesis contributes to several aspects of the inference of tumour evolution. My
main contribution is a method to infer tumour evolution from single-cell sequencing data.
Furthermore, I led the evolutionary analysis of a study of ten lethal metastatic breast
cancers and adapted existing methods to infer tumour evolution from multi-sample bulk
sequencing data.
This first chapter gives an overview of tumour evolution and the challenges it poses for
treating the disease (Section 1.1). It explains different sequencing approaches to analyse
the genomic markers of tumour evolution and describes the main challenges for inferring
tumour phylogenies (Section 1.2).
1.1 Tumour evolution
The somatic evolution of cells within a multicellular organism explains both how cancer
arises and why curing it is so difficult [104]. Advances in genome sequencing have enabled
researchers to study the mutations of a tumour at an unprecedented resolution. However,
sequencing on its own reveals little about the development and the genetic heterogeneity of
a tumour. Computational methods are needed to infer tumour phylogenies, which describe
the evolutionary history of a tumour while also providing information about the genetic
heterogeneity within the tumour at the time of sampling. Inference of tumour phylogenies is
the main topic of this thesis.
Cancer development Cancer develops through an evolutionary process, which is based
on two fundamental biological processes (i) the accumulation of mutations and (ii) natural
selection acting on the phenotypic differences caused by the mutations. Cells acquire
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mutations through various mechanisms including exposure to mutagens as well as cell-
intrinsic processes such as the replication of deoxyribonucleic acid (DNA) [158]. Most
mutations do not have an effect on the phenotype of the cell and are called neutral or
passenger mutations [166]. Alternatively, they can be disadvantageous, in which case they
may slow down cell division or cause cell death. Some mutations, however, can change the
phenotype of a cell in a way that confers a growth advantage, i.e. they increase the ratio
of cell birth to death. These mutations are called drivers [166]. If a cell acquires such a
mutation, this can lead to an increased proliferation of the cell compared to its neighbours.
This is called a clonal expansion [115]. Clonal expansions of cells are common in the human
body. Most of these clones have a limited growth potential and lead to benign growths like
skin moles [158]. The accumulation of mutations, however, does not have to stop there.
Cells within an expanding clone accumulate further mutations. A descendent clone carries
all mutations of its parent clone in addition to its newly acquired mutations. This leads to
a subset pattern of mutations, where early clones contain a subset of the mutations of the
later clones. Through this multi-step process of accumulation of advantageous mutations and
subsequent clonal expansions, a single founder cell can grow into a heterogeneous tumour
mass.
Eventually, cells can become cancerous, which means that in addition to the uncontrolled
division of tumour cells, they acquire the ability to invade nearby tissues and spread to
distant organs through the bloodstream to form metastases [56]. Metastatic cancer is largely
incurable, and more than 90% of cancer deaths are due to metastases [162], highlighting the
importance of studying this process. Emerging evidence indicates that the spreading of cancer
cells can occur through multiple routes and in different directions [161, 93]. Metastases can
be seeded by clusters of circulating tumour cells [1]. Cells that have been generated through
the ongoing evolution within a metastasis can invade another already existing metastasis in
a process called cross-metastasis seeding [161]. Furthermore, cells from a metastasis can
re-infiltrate the primary tumour (self-seeding). In combination, these processes can lead to
complex mixtures of cell populations within the primary and metastatic sites.
The mutational landscape of tumours During tumour evolution cells acquire different
types of mutations. A very common type are single-nucleotide variants (SNVs) [3]. These
are single base-pair substitutions. Mutations that affect more than one base-pair are called
structural variants which include indels [3], copy number aberrations [175] as well as
inversions and translocations [106]. Indels are mutations that lead to a small insertion or
deletion of one or a few nucleotides. Copy number aberrations (CNAs) in contrast lead to
gains or losses of large parts of the genome, ranging in size from a few kilobases to whole
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chromosomes. In addition to genetic changes, epigenetic changes can also play a role in
tumour evolution [77, 61].
The time frame of cancer evolution is extremely variable, ranging from years to several
decades [8, 52]. This also applies to the rate at which mutations occur. While mutations may
accumulate slowly at the beginning of tumour development, the mutation rate can increase
once genes that, under normal circumstances, are responsible for maintaining a stable genome
have been mutated themselves [87, 11, 88]. Consequently, the number of mutations found
in tumours varies widely. It is particularly small in paediatric tumours, which develop over
short time frames and harbour an average of 9.6 non-synonymous mutations per tumour.
Non-synonymous mutations are mutations that change the encoded amino acid sequence of a
protein [171]. Melanomas and lung tumours show a high number of mutations containing
approximately 200 non-synonymous mutations per tumour, reflecting the role of mutagens in
the aetiology of the disease [166]. Tumours that have deficiencies in DNA damage repair
pathways can harbour thousands of non-synonymous mutations [166]. For breast cancers,
which are the subject of study in Chapter 4, the median number of non-synonymous mutations
is estimated to be around 33 [166].
Selective forces shape tumour evolution The proliferative success of a tumour cell
depends on its genetic background and the resulting consequences on the phenotype of the
cell. Whether or not a mutation acts as a driver or passenger can change over time as it
depends on the selective pressures acting on the cell. Furthermore, it can depend on the
genetic background of the cell in which it occurs [154]. Nevertheless, researchers have
defined a list of driver genes which are considered to be relevant for cancer development if
mutated in certain ways or aberrantly expressed [166]. Usually, the vast majority of mutations
in a tumour are passengers, with the number of driver gene mutations in a typical tumour
ranging from two to eight [166].
Examples of selective pressures acting on the phenotypic differences caused by mutations
are competition for space and resources such as oxygen. Other constraints are imposed by the
tissue microenvironment, for example through the immune system, which can select against
cells containing neoantigen-causing mutations [171]. Cancer treatments can be an extreme
form of selective pressure, ideally eradicating all of the tumour cells but none of the normal
ones. Emerging evidence suggests that in some cases tumours might not be subjected to any
strong selective pressures, leading to neutral evolution, in which all the different clones in
the tumour expand at the same rate [157].
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Treating cancer in the light of evolution Tumour evolution has important implications
for cancer treatment and outcome. Since the accumulation of mutations is a stochastic process,
every cancer is different, a phenomenon called inter-tumour heterogeneity. Consequently,
response to treatment is variable and there is a need for personalised treatments that are
tailored towards the molecular features of the disease. In response to this, molecular subtypes
have been defined for many cancer types, such as breast cancer [121, 156, 22], glioblastoma
[165] and pancreatic cancer [7]. Subtypes have been shown to be prognostic of patient
outcome and cancers of some subtypes show distinct responses to certain treatments [128].
Often subtype definitions are based on gene expression patterns only [121, 156], but some
also integrate genomic features in the classification [22, 7] or were subsequently used to
identify genomic features that are associated with subtypes [165].
In addition to inter-tumour heterogeneity, tumour evolution also leads to intra-tumour
heterogeneity. This means that cells within a tumour differ from each other. This hetero-
geneity manifests itself spatially and temporally [150]. Accordingly, biopsies from a single
region are unlikely to reveal the full heterogeneity of a tumour [50]. Nevertheless, single
biopsies are commonly used to inform treatment decisions [50], because of the difficulties
and risks associated with obtaining tissue biopsies [21]. This can thwart therapeutic suc-
cess, as to avoid relapse, all cell populations within a tumour need to be eradicated by the
treatment. Often, tumours shrink initially upon treatment administration but later regrow
due to a resistant cell population. This can be caused by resistant cells that were already
present in the tumour before the treatment [64, 29] or, given that tumours keep evolving
for as long as they exist, by new mutations that were acquired during treatment [5]. In
fact, emerging evidence suggests that therapeutic intervention can accelerate the growth of
resistant populations by inducing new mutations and removing competing populations that
are sensitive to the treatment [52, 70, 74].
To detect signs of regrowth earlier, methods that to monitor the treatment response non-
invasively through circulating tumour cells [119, 89] and circulating tumour DNA (ctDNA)
[30, 42] from liquid biopsies are being developed.
Why study tumour evolution? Given that every cancer is different, studying the evolu-
tion of a tumour long after a patient has died may seem futile. However, cancer development
can be seen as a repeated evolutionary experiment [154]. Unlike the evolution of species,
which is a single experiment that started billions of years ago and is still ongoing, cancer
starts over and over again with every patient. Even though the exact genetic makeup of
each cancer is different, the conditions in which cancers evolve are similar. This imposes
constraints that may limit the range of possible trajectories for cancer evolution [154]. A
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consequence of these mechanistic commonalities are the recurrently mutated cancer driver
genes mentioned above.
Reliable methods for the inference of tumour life histories are important for several
reasons. Inferring trees of evolution across many patients may help elucidate the unifying
patterns of tumour evolution at a higher resolution. For example, instead of only analysing if
a gene is mutated in a tumour, inferring trees enables us to test whether certain combinations
of mutations occur in the same subpopulations. It may also provide the opportunity to obtain
a clearer picture of the evolutionary dynamics of tumours, which could be a major stepping-
stone towards enhanced treatment strategies for cancer. In the future, phylogenetic trees
could also be of use in the clinic, as they enable the identification of clonal mutations which
are likely to be better targets for therapy than subclonal mutations [117, 120]. Ultimately,
studying tumour evolution could enable researchers to predict the next evolutionary step of a
tumour [62] and could help to turn cancer into a manageable chronic disease, similar to HIV
where treatment strategies are guided by evolutionary principles to slow down the emergence
of resistance and the progression of the disease [37].
1.2 Inferring trees of tumour evolution
The evolution of cancer is not a new concept. In fact, Theodor Boveri already hypothesised
more than 100 years ago that “every tumour has its origin in a single cell”, which contains
a “faulty assembly of chromosomes as a consequence of an abnormal event” and that
the transformation from benign to malignant tumours is due to further changes in the
chromosomes [14]. His theories were developed through cytological observations. Peter
Nowell consolidated the theoretical framework for clonal evolution in his seminal paper
from 1976 [115]. His conclusions were, however, still mainly drawn from observations at
the chromosome level.
Rapid advances in sequencing technologies in recent years have dramatically changed
our ability to analyse genomic changes. Genomes can now be studied at base-pair resolution
at relatively low cost. Nevertheless, inferring the evolutionary history of a tumour remains
challenging. The following section gives a brief overview of the basic approaches to inferring
tumour phylogenies. It mainly focuses on SNV based methods as these are the most common
ones. A more detailed description, including copy number based methods, can be found in
Chapter 2.
Bulk versus single-cell sequencing Most methods developed for the inference of tumour
evolution use data derived from bulk sequencing of tumour samples. Bulk sequencing means
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that the genetic material of all cells in the sample is pooled and sequenced. The resulting
sequencing reads cannot be traced back to the individual cells and the genotypes inferred are
therefore a combination of the different cell populations in the sample. There are two main
types of approaches for the inference of trees of tumour evolution from bulk samples.
The first kind of approach builds sample trees and can only be used if multiple, phylo-
genetically related samples are available [151, 81, 132]. It assumes that every bulk sample
contains cells of a single population. If this assumption is violated, the inferred sample
tree still reflects similarities between samples, but these can differ from the true underlying
phylogenetic relationships [4].
The second type are deconvolution based approaches [139, 105, 27]. Unlike the sample
tree approaches, these methods do not assume that all mutations of a sample occurred in
a single population. Most deconvolution based methods consist of two inference steps.
First, they deconvolve the mixed signal of the bulk sample to infer clusters of mutation
which occurred together during tumour evolution [139]. In the second step, mutation cluster
frequencies are used to infer evolutionary relationships between the clusters [126]. Together,
the mutation clusters and their relationships define the genotypes of the subpopulations in
the sample. Deconvolution-based approaches can be applied to both single and multiple
samples [139, 105]. However, using multiple samples helps to infer the population structure
at a higher resolution [68]. Furthermore, mutation cluster frequencies of a single sample are
often compatible with multiple tree structures. In certain cases, multiple samples can resolve
these ambiguities.
Recently, single-cell sequencing techniques have been developed. Unlike the mixed signal
of bulk-sequencing, single-cell sequencing provides information about the co-occurrence
of mutations. Multiple single-cell sequences are needed to infer a tree, and ideally, these
cells should be a representative sample of the different subpopulations in the tumour. If
genotype inference using single-cell sequencing was perfect, inferring the phylogeny of the
cells could be done using classic phylogenetic methods such as maximum parsimony or
neighbour-joining. However, due to technical limitations, variants inferred from single-cell
sequencing are very noisy [169, 58]. Consequently, standard methods often fail to identify
subpopulations within the sequenced cells, turning even a seemingly simple task, such as
mapping cells to clones, into a challenge. This thesis contributes to the challenge of inferring
trees from SNVs of single cells. It proposes a probabilistic model that exploits the subset
relationships of mutation patterns between related cells and accounts for genotyping errors
and missing data.
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Data pre-processing Most point mutation based approaches require binary present/absent
calls, read depths of the reference and mutant alleles or variant allele frequencies. These
can be obtained using standard variant callers. Germline mutations are usually filtered out
using matched normal samples, as only somatic mutations are informative about the structure
of tumour phylogenies. In the following, we refer to these mutations as SNVs. In general,
however, point mutation based methods apply to all mutations that can be considered as
independent from each other, including indels.
Data pre-processing for copy number based approaches is often more difficult. There
are two main challenges, which are related to the two main steps of inferring copy number
profiles. First, the genome has to be segmented into regions of constant copy number [114].
Second, relative copy number values need to be converted into absolute integer values by
estimating the ploidy and purity of the sample [164]. To date, the segmentation of allele-
specific copy number data has been done on a per sample basis, even when multiple related
samples are analysed. Noise in the data can cause misalignment of segment boundaries that
are shared between related samples, which in turn leads to problems during tree inference.
This thesis presents an allele-specific multi-sample segmentation algorithm to address this
problem.
Benchmarking One of the biggest limitations for method development in the area of
tumour phylogenies is the lack of a gold standard data set for method benchmarking. For any
tumour, the ground truth tree is unknown, and new methods are often only validated using
simulated data, which always contains biases.
At the same time, many of the application studies that infer trees only use a single method.
This is partially because studies often only generate a single type of data, which in turn limits
the range of methods that can be used. It is, however, difficult to estimate the uncertainty
in the tree based on a single method, as many tools only generate a single solution that
may seem definitive to the user. While resampling approaches like bootstrapping could be
used to assess the stability when only one method is used, this is rarely done. Furthermore,
resampling might not address method specific artefacts in the tree reconstruction.
The danger of ignoring uncertainty in the tree inference is that the biological conclusions
drawn could be a consequence of artefacts in the tree reconstruction. Artefacts could include
the inferred relationships between samples, the branch lengths as well as instances of spurious
convergent evolution [4].
In an attempt to provide a more realistic benchmarking scenario for methods inferring
tumour evolution, ICGC and TCGA jointly initiated a DREAM challenge (ICGC-TCGA-
DREAM Somatic Mutation Calling Challenge –Tumor Heterogeneity and Evolution) [143].
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The challenge consisted of several tasks, including the inference of tumour purity, the number
of mutation clusters, their cellular prevalence and the phylogenetic relationships between
subpopulations. The challenge was, however, limited to the benchmarking of single-sample
bulk methods. A comprehensive comparison of multi-sample methods is still lacking.
To infer trees as part of an autopsy study, we decided to use a comprehensive set of
multi-sample methods. Some of these methods infer sample trees while others perform
deconvolution of subpopulation as part of the tree inference. Furthermore, the methods vary
in the input data they require and the type of variants they analyse, with some being SNV
based and others being copy number based or a combination of the two. This is possible due
to the large variety of sequencing data available for the same tumour in this study, which
included shallow whole genome sequencing, whole exome sequencing and targeted deep
sequencing.
1.3 Thesis organisation
In summary, to infer tumour phylogenies, challenges need to be addressed at every level of
the data analysis process (i) data pre-processing, in particular for copy number segmentation,
(ii) tree inference, in particular in the area of single-cell phylogenies, and (iii) benchmarking
of tree inference algorithms in realistic settings. This thesis contributes to all of these three
components. The organisation of the thesis is outlined in the following.
Computational approaches to inferring tumour evolution Chapter 2 provides an
overview of current approaches to inferring tumour phylogenies. It describes the basic
principles and assumptions behind inference methods for tumour evolution. It focuses on
methods that have been used to infer phylogenies from single-cell data and bulk sample-based
approaches that are applicable to multiple related samples.
Inferring tumour evolution from single-cell sequencing data In Chapter 3 we de-
velop a method for inferring clonal lineage trees from single-cell sequencing data. The main
assumption of this method is that genotypes of the different cells are connected through
subset relationships, which reflect the accumulation of mutations during tumour evolution.
Unlike previous methods, we probabilistically account for genotyping errors to model the un-
certainty associated with variant calls from single-cell sequencing. Furthermore, we develop
a search algorithm, to efficiently search the space of possible trees. We validate our approach
in simulation studies and apply it in two case studies.
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Inferring tumour evolution using multi-sample bulk sequencing data Chapter 4
focuses on the inference of tumour phylogenies from bulk sequencing data of multiple related
samples. We first present a new algorithm for allele-specific multi-sample segmentation to
reduce noise in multi-sample copy number data. We then use this approach in combination
with a representative set of multi-sample phylogeny methods to study the evolutionary history
of 10 cases of lethal metastatic breast cancer. Depending on the method requirements we
use shallow whole genome, whole exome or targeted sequencing data of the same samples.
The chapter concludes with a comprehensive comparison of the inferred phylogenies across
methods and data types to assess the robustness of the results.

Chapter 2
Computational methods for inferring
tumour evolution
In this chapter I describe computational models for inferring tumour evolution. I start
with defining the aim of tumour phylogenetics (Section 2.1) and describe the common
evolutionary assumptions inference models are based on (Section 2.2). Section 2.3 reviews
bulk-sequencing methods, while Section 2.4 discusses single-cell based approaches. This
chapter contains text from Ross and Markowetz [136] and a figure from Ross and Markowetz
[137].
2.1 Aim of tumour phylogenetics
Tumour phylogenetics aims to infer a tree that describes the evolutionary history of a tumour.
Each node of the tree corresponds to a subpopulation of the tumour that is characterised by a
distinct genotype. Leaf nodes correspond to current subpopulations that have been observed in
the tumour sample. In contrast, internal nodes correspond to ancestral populations. Different
from the evolution of species, ancestral populations do not have to be driven to extinction by
tumour evolution. Therefore, internal nodes can describe observed or unobserved ancestral
populations. Populations can be unobserved due to extinction, or because they have not been
sampled. The edge connecting two nodes corresponds to the mutations that distinguish the
respective subpopulations. The number of mutations assigned to an edge is often encoded in
its length. To reflect the process of evolution edges are directed.
In case of single-cell sequencing, each sample corresponds to a single subpopulation
and can, therefore, be assigned to a single node of the tree. In case of bulk-sequencing, a
sample can contain cells from multiple subpopulations. To describe the composition of a
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bulk sample, edges are drawn from its constituent subpopulations to the sample, yielding a
directed acyclic graph.
2.2 Assumptions
To reconstruct tumour phylogenies we have to make assumptions about how tumours evolve.
Most methods make the following two assumptions. Firstly, every site is only mutated
once. This is often referred to as the infinite sites assumption [91]. Secondly, mutations
do not revert or disappear. Combined, these assumptions describe a perfect and persistent
phylogeny, where mutations accumulate over time and are never lost [13]. These assumptions
are not always justified. For example, deletions leading to loss of heterozygosity can remove
previously acquired mutations.
The main alternative to these assumptions are maximum parsimony or minimum evolution
methods, which are based on the principle of Occam’s razor. These approaches allow
for multiple changes including back mutations at the same site but assume that the true
underlying tree is the one that requires the lowest number of changes to explain the data [38].
Noisy data can, however, limit the applicability of these approaches.
2.3 Bulk-sequencing based methods
Bulk samples can contain cells from multiple subpopulations. Most bulk-sequencing based
methods aim to identify the different subpopulations in one or multiple related samples
as well as their phylogenetic relationships. This section gives an introduction to the most
commonly used approaches in this field. An overview of bulk-sequencing methods is shown
in Table 2.1 at the end of this section.
2.3.1 Data
Currently, the most commonly used sequencing technologies produce short reads. Illumina’s
HiSeq 4000 platform, for example, generates reads with a maximum length of 2× 150
base-pairs [63]. As point mutations are distributed sparsely across the genome, a single
read rarely covers multiple mutations [174]. At the same time, bulk sequencing reads do
not contain information about their cellular origin. Therefore, we cannot tell if two reads
stem from the same or different cells. In summary, this means that bulk sequencing does not
provide direct information about which mutations occur together in a cell. In the future, this
might improve due to longer sequencing reads or synthetic long reads [122, 79]. Given the
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current setting, however, computational methods are needed to infer the co-occurrence of
mutations.
2.3.2 Basic idea
Most bulk methods identify groups of co-occurring mutations by clustering them according
to their frequency. The motivation behind this approach is based on the perfect and persistent
phylogeny assumption described above. Under this assumption, two mutations, A and B,
that occurred at the same time in the same cell are always inherited together. This means
that all cells that carry A also carry B and vice versa. Therefore, the cellular prevalences of
these mutations are equal [139], where the cellular prevalence of a mutation is defined as the
fraction of cancer cells that carry the mutation. It is also referred to as cancer cell fraction
(CCF) [84].
Having the same cellular prevalence is a requirement for co-occurrence, but is not
sufficient. Mutations that have the same frequency do not have to appear in the same cell.
They could, for example, belong to different subpopulations that happen to have a similar
cellular prevalence in the sample. Nevertheless, many deconvolution-based methods infer
the co-occurrence of mutations purely based on mutation frequencies.
Once mutations have been clustered, cluster frequencies are used to infer phylogenetic
relationships. In the following, we explain the clustering and tree reconstruction approaches
in more detail. First, however, we describe how mutation frequencies are estimated from the
sequencing data.
2.3.3 Estimating mutation frequencies
Bulk genome sequencing enables us to identify mutations and provides estimates of their
variant allele frequencies (VAFs). The VAF of a mutation is the relative frequency of the
variant allele in the population. It can be estimated directly from the sequencing data as
the fraction of reads carrying the mutant allele. Naturally, the accuracy of VAF estimates
increases with sequencing depth. To infer mutation clusters, VAFs need to be transformed
into cellular prevalences. The cellular prevalence of a mutation differs from its VAF for three
main reasons.
• Germline ploidy For diploid genomes, the fraction of cells carrying the mutation
is twice as high as its VAF because every cell that carries the mutation contains one
mutant and one wild-type allele.
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Fig. 2.1 The effect of a copy number change on the frequency of a variant allele (red
dot) in the population depends on the phylogenetic relationship between the two mutation
events. Various VAFs can correspond to the same cellular prevalence of the variant allele
(CCF). The last case, where SNV and CNA lie on different branches, assumes that the two
populations are present in equal proportions.
• Purity Tumour samples usually contain a mixture of tumour and normal cells. The
purity, also referred to as cellularity, measures the fraction of tumour cells in the
sample. Most methods require this as an input parameter. It is often estimated
using copy number inference tools such as ASCAT [164] and ABSOLUTE [16].
Alternatively, it can be estimated from histopathology images of the tumour [139]. A
low purity leads to small VAFs.
• Copy number changes The VAF of a mutation depends on the number of copies of
a locus in a cell. In a normal diploid cell, this is two. Due to copy number changes the
number of copies of different loci can vary widely.
Accounting for purity and germline ploidy is straightforward, as they affect the relationship
between VAF and cellular prevalence in the same way for all mutations. Local copy number
changes, in contrast, can affect VAFs in different ways. Apart from the location of SNV and
CNA, the effect depends on the phylogenetic relationship between these mutations. This
makes accounting for copy number changes much more difficult. Examples of how CNAs
can impact VAFs are shown in Figure 2.1. To complicate things even further, copy number
changes can overlap. This means that the VAF of a single point mutation can be affected by
several copy number changes with independent phylogenetic relationships.
Most methods do not contain built-in functions to adjust VAFs for copy number changes.
Some ignore copy number changes entirely, which can lead to spurious mutation clusters (see
Figure 2.2). Others recommend excluding mutations that fall into regions of copy number
changes [105, 176]. Copy number changes can, however, affect large parts of the genome.
Therefore, restricting the analysis to regions without copy number changes may discard much
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Fig. 2.2 Copy number changes (Case 1) and intra-tumour heterogeneity (Case 2) can both
lead to a multi-modal distribution of variant allele frequencies. SNVs marked by dots are
representatives of a much larger number of variants with the same phylogenetic history.
Variant allele frequencies of each cluster show dispersion due to the noise introduced in the
data generation process.
of the phylogenetic information, including disease-relevant driver mutations, limiting the
biological interpretation of the inferred phylogenies. Furthermore, the clustering approaches
that are used in the subsequent analysis require sufficiently large data sets to yield good
results. For these reasons, robust estimation of cellular prevalences is an important part of
the phylogenetic analysis.
PyClone [139] is one of the methods that model the impact of copy number changes
on VAFs. It does this by integrating over the different possible relationships between CNA
and SNV. However, it does not take into account the case where CNAs and SNVs occur in
independent populations and makes further simplifying assumptions about the co-occurrence
of CNA and SNV events that disregard some of the possible genotype states [139, 27, 84].
CHAT [84], PhyloWGS [27] and SuperFreq [145] estimate the phylogenetic relationship
and take all of the possible phylogenetic combinations between an SNV and a single CNA
into account. CHAT assigns phylogenetic relationships and explicitly calculates cellular
prevalences using a probabilistic model that excludes ambiguous cases. SuperFreq, in turn,
assigns phylogenetic relationships where possible and increases the uncertainty of the cellular
prevalence estimates in ambiguous cases. PhyloWGS does not explicitly calculate cellular
prevalences for each variant but instead incorporates the effect of copy number changes
in its probabilistic clustering model. Rather than picking one phylogenetic relationship
or marginalising over them, EXPANDS [6] calculates distributions of possible cellular
prevalence values and clusters these distributions to infer mutation clusters. However, like
PyClone it does not take into account all of the possible combinations of CNAs and SNVs.
Alternatively, where methods do not account for copy number changes, cellular preva-
lence estimates of third-party tools can be used as input instead of VAFs. One such tool,
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which purely focuses on the estimation of cellular prevalences, is OncoPhase [17]. It uses the
VAFs of phased germline variants as additional information for inferring the order between
CNAs and somatic SNVs.
All of these approaches make important advances towards a more accurate estimation of
cellular prevalences. Nevertheless, limitations remain due to the complexity of the problem.
The common copy number inference tools infer copy number states of a single or at most
two aberrant cell populations [27]. Heterogeneous samples can, however, contain many
more subpopulations. In these cases, the estimated copy numbers are a mixture of the
different subpopulations. This can lead to inaccuracies in the cellular prevalence estimates.
Furthermore, the infinite sites assumption does not hold for CNAs because they involve large
parts of the genome. Therefore, SNVs can be affected by multiple copy number changes
with different phylogenetic relationships. This is generally not taken into account.
2.3.4 Clustering approaches
Assuming that cellular prevalences have been estimated, the next step is to infer mutation
clusters. The most commonly used method for clustering mutation frequencies are mixture
models. Mixture models in different variations are used by SciClone [105], PyClone,
PhyloSub [68], PhyloWGS, CHAT, LICHeE [126] and CTPsingle [31]. The following
section gives a brief introduction to mixture models.
2.3.4.1 Model-based clustering
Mixture models describe the data distribution f (x) as a mixture of component distribu-
tions [43]
f (x) =
K
∑
k=1
πkF(x|θk), (2.1)
where K is the number of mixture components, πk are the mixing proportions of the different
components with ∑Kk=1πk = 1 and F(x|θk) is the density function of the mixture components
with component specific parameters θk. The component density depends on the type of data
being analysed. LICHeE and CHAT use Gaussian distributions to model mutation frequencies.
PhyloSub, PhyloWGS, Clomial [176], CloneHD [39], Canopy [67] and TITAN [53] model
counts of normal and variant alleles using binomial distributions, while PyClone, CTPsingle
and Cloe [97] use beta-binomial distributions. Copy number read depths are modelled
through multinomial distributions by THetA [116] and TITAN.
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Inference Direct inference of the parameters that meet the maximum likelihood criterion
is difficult. They can, however, be estimated using the Expectation Maximisation (EM)
algorithm, as done by LICHeE. The EM is a general iterative optimisation algorithm. In the
setting of mutation cluster inference, the algorithm alternates between assigning component
responsibilities to each mutation (expectation step) and updating component parameters
(maximisation step) [57].
Model selection Model-based clustering and other techniques used for tumour phylogeny
inference require the number of components as input parameter. Since the number of
subpopulations is not known a priori and to avoid overfitting, model selection is needed. To
do this, models with varying numbers of clusters are inferred, and a selection criterion is used
to choose the preferred model. Many different selection criteria exist. Methods including
THetA, Clomial, CloneHD and Canopy use the Bayesian Information Criterion (BIC), which
penalises for the number of parameters in the model. The BIC is defined as
BIC =−2 · Lˆ+ log(N) ·d, (2.2)
where Lˆ is the log-likelihood of a given model, N is the number of data points, and d is
the number of free parameters of the model [57]. TITAN uses a measure called S_Dbw
validity index [55], which minimises the variance within each cluster and maximises the
density-based separation between clusters.
2.3.4.2 A Bayesian approach to mixture models
Instead of using model selection, mixture models can be extended to fully probabilistic
non-parametric models that treat the selection of the number of components as part of the
inference problem. The core of these approaches is a probabilistic model that is derived using
a Bayesian framework, and that describes how the observed data is generated.
Finite mixture models Assuming the number of components K is known, defining the
generative model is straightforward [51]: As in the simple mixture model case, the data stems
from a set of component-wise distributions F(x|θk). However, the component parameters θk
and component weights πk are unknown a priori. For this reason, we treat them as variables,
which follow certain probability distributions, so called priors. A convenient choice for
the component weight prior is the Dirichlet distribution, which models the probability of
K competing events. The prior over the component parameters depends on the data that is
being analysed. In the following we denote it as G0(θk). This defines a joint distribution over
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the data points x = {x1, . . . ,xN}, their cluster assignments c = {c1, . . . ,cN} and the cluster
parameters θ = {θ1, . . . ,θK}
P(x,c,θ) =
K
∏
k=1
G0(θk)
N
∏
n=1
F(xn|θcn)P(cn), (2.3)
where P(cn) is the component weight prior for data point n with cn ∈ {1, . . . ,k}.
Infinite mixture models As mentioned above, K is usually unknown and needs to be
treated as a variable, too. This can be achieved using a probabilistic model called Dirichlet
process. Like the sample from a Dirichlet distribution, a sample from the Dirichlet process
can be interpreted as a sample of component weights. Instead of producing a fixed number
of components K, however, the Dirichlet process generates an infinite number, where the
component weights still sum up to 1. This is achieved by an iterative sampling procedure,
where the weight of component k is sampled as
πk ∼ Beta(1,α)
(
1−
k−1
∑
j=1
π j
)
. (2.4)
Due to the infinite number of components these models are also called infinite mixture models.
Alternatively, they are referred to as Dirichlet process mixture models [51]. Despite the name,
the number of components that are populated by data points are finite in practice, because
the number of data points is finite itself. Consequently, the clustering solution will consist of
a finite number of clusters, too.
An intuitive way to understand the Dirichlet process is the stick breaking construction [2].
Given a stick of unit length, a piece of length πk is broken off the stick, where πk is
determined by a draw from a Beta distribution Beta(1,α). The remaining stick is used
for the next stick breaking step. This procedure is repeated an infinite number of times
to generate the component weights. As the remaining stick becomes smaller and smaller,
the sampled component weights become smaller too. The sampling procedure of Dirichlet
process mixture models is summarised in Figure 2.3.
Inference The aim is to infer the posterior probability of cluster assignments given the
data P(c|x). This is usually achieved using Bayes theorem. However in case of both finite
and infinite mixture models, the posterior is intractable because it requires summing over
all possible partitionings of the data with K components [51]. Nevertheless, the generative
model enables us to approximate the posterior distribution. The most common procedure to
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Fig. 2.3 Visual summary of the Dirichlet process mixture model sampling procedure.
do this is Markov Chain Monte Carlo (MCMC) sampling, which generates a sample from
the posterior distribution. It is used by CHAT, PyClone, CTPsingle, PhyloSub, PhyloWGS
and Canopy. The disadvantage of this approach is that a large number of steps may be
required until the Markov Chain reaches its equilibrium distribution and it is difficult to
assess convergence [12]. An alternative approach, variational Bayes, is used by SciClone.
Instead of sampling, variational Bayes approximates the posterior distribution with a simpler
family of distributions and minimises the Kullback-Leibler divergence between posterior and
the approximative distribution [12]. An advantage of variational Bayes over MCMC is that it
is usually faster, and convergence can be easily assessed, but it may yield biased results [51].
2.3.4.3 Clustering multiple samples
As explained above, frequency-based clustering may erroneously group mutations of dif-
ferent subpopulations, if they have the same cellular prevalence. Additional samples can
increase the resolution of the clustering solution if they contain different fractions of the
subpopulations [68] (see Figure 2.4). Most mixture model-based methods can cluster cel-
lular prevalences of multiple related samples simultaneously by using multi-dimensional
distributions.
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Fig. 2.4 Toy example of mutation clustering based on two samples. In sample 1 the
two low frequency clusters (red and light blue) have the same cellular prevalence and can
therefore not be distinguished. In sample 2, the two cluster occur at different frequencies
and can therefore be resolved.
2.3.5 From mutation clusters to trees
In the following, we assume that mutations have successfully been clustered into groups.
Many methods stop at this point and do not infer phylogenies. It is, however, important to
note that mutation clusters do not directly correspond to the genotypes of the subpopulations.
Each mutation cluster is thought to be the result of a clonal expansion. A subpopulation
may, however, be the result of several successive rounds of clonal expansions. Therefore, the
genotype of a subpopulation may be a combination of several mutation clusters.
To obtain the full SNV genotypes of the tumour subpopulations the phylogenetic rela-
tionships between mutation clusters need to be inferred. In this step, methods rely again on
the perfect and persistent phylogeny assumptions described in Section 2.2. They can be used
to derive two rules constraining the possible topologies of tumour phylogenies, called the
sum rule and the crossing rule [68].
Sum rule The sum rule states that in a branching phylogeny where A is ancestral to both B
and C, the sum of population frequencies of B and C must be lower or equal to the population
frequency of A. If this is not the case, the phylogeny must be linear. This rule is also called
the pigeonhole principle [112]. Consider the following example of three mutation clusters A,
B and C, with CCF(A) = 0.8, CCF(B) = 0.6 and CCF(C) = 0.4. A and B cannot belong to
different branches of the phylogeny because the sum of their population frequencies is larger
than 1. A sum larger than 1 could only be explained with a violation of the infinite sites
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assumption. The same applies to A and C. Therefore, A must be an ancestor of both B and C.
B and C in turn cannot belong to different branches, because CCF(B)+CCF(C)> CCF(A).
The sum rule can be applied to single as well as multiple samples.
Crossing rule The crossing rule states that two clusters A and B must belong to differ-
ent branches of the phylogeny if CCF(A)> CCF(B) in one of the samples and CCF(B)>
CCF(A) in another sample.
Since the crossing rule relies on multiple samples, the mutation clusters of a single
sample are not sufficient to rule out a linear phylogeny, and even with multiple samples,
these constraints do not always define a unique phylogeny. Likewise, it is possible that the
frequencies of mutation clusters across multiple samples define incompatible phylogenies.
This is because the methods described above infer mutation clusters without taking into
account phylogenetic constraints.
Sum and crossing rules are used by all methods that infer phylogenies from mutation
clusters, but methods differ in details of how they apply them. LICHeE, for example, requires
an error range for cluster CCFs as input parameter and takes this into account when inferring
the ordering between clusters. SCHISM [113] performs a hypothesis test for each pair of
mutations (i, j) to infer if mutation i can be an ancestor of mutation j. In a second step,
it aggregates the votes of each mutation pair across clusters to infer if cluster I can be an
ancestor of cluster J. The resulting matrix is then used to infer phylogenies. Methods also
differ in how they report ambiguities in the tree topologies. LICHeE infers multiple tree
topologies, whereas PhyloWGS and PhyloSub report partial order graphs if unique solutions
cannot be inferred. SuperFreq in turn always assumes a linear relationship, unless it can be
ruled out via the crossing rule.
2.3.6 Other approaches
2.3.6.1 Joint clustering and tree building
Some methods attempt to infer clusters and tree structure jointly, to avoid the problem of
phylogenetically incompatible mutation clusters.
PhyloSub and PhyloWGS use a tree structured stick breaking process [2]. This mix-
ture model approach uses a tree-structured prior instead of a flat Dirichlet process prior
to simultaneously infer clonal genotypes and their phylogenetic relationship. Like most
mixture model-based methods, PhyloSub and PhyloWGS use MCMC sampling for inference.
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However, the large space of possible phylogenetic trees can be problematic for sampling
methods [35].
Other methods aim to decompose the observed data matrix of mutations across samples
into a matrix of clonal genotypes (|mutations|× |clones|) and a matrix of clone frequencies
(|clones|×|samples|). Varieties of this approach are used by CITUP [95] and AncesTree [34].
TrAp [159] aims to infer clonal genotypes from a single sample in a similar fashion but has
to make strong additional assumptions such as sparsity constraints to address identifiability
issues.
Clomial also uses matrix decomposition but does not impose phylogenetic constraints on
the genotype matrix. The result may therefore not be compatible with a tree structure. Most
of these methods infer solutions using integer linear programming (ILP) optimisation.
2.3.6.2 Relaxed phylogenetic assumptions
El-Kebir et al. [35] developed SPRUCE, which infers a multi-state perfect phylogeny. In this
setting, a locus can change its state multiple times but may only change to the same state
once. This is called the infinite alleles assumption. Marass et al. [97] developed a latent
feature model, called Cloe, which allows for loss of mutations and convergent evolution.
2.3.6.3 Sample-based methods
In contrast to deconvolution-based approaches, other methods build trees directly on the
mutation profiles of multiple samples of the same tumour. These methods either assume
that mixing of subpopulations in a sample is rare or that each sample consists of a single
subpopulation.
Limited mixing of subpopulations Recently, Reiter et al. [132] developed a point
mutation based method called Treeomics, which assumes that samples rarely contain a mix
of subclones from independent branches of the phylogenetic tree. While this cannot be
assumed for primary tumours, previous research suggests that it may be a suitable assumption
for samples from metastases, as metastasis formation is a bottleneck that reduces genetic
diversity [103, 80, 161].
As input Treeomics uses two matrices of mutation sites versus samples, containing the
total number of reads and the number of mutant reads. Based on the number of reference and
mutant alleles, Treeomics calculates the posterior probability of a mutation being present
at a given site in a given sample. It then extracts binary mutation patterns from the data,
where each mutation pattern is defined by the set of samples which contain the variant.
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For every unique mutation pattern, a reliability score is calculated based on the posterior
mutation probabilities. Finally, a mixed integer linear program (MILP) solver is used to
find the set of compatible mutation patterns which maximises the total reliability score.
Mutation patterns are considered compatible if they do not violate the perfect and persistent
phylogeny assumption. The compatible mutation patterns define the inferred phylogeny. In a
post-processing step, incompatible mutation patterns with a high reliability score are used to
identify mixing of subpopulations within samples. An advantage of this approach is that it
does not rely on mutation frequencies to identify co-occurrence of mutations.
No mixing of subpopulations If samples consist of a single subpopulation, they can
be used directly to build trees. Trees, where samples are directly assigned to nodes, are
called sample trees [4]. Even though the assumption of a single subpopulation per sample
may not hold, sample tree methods can be useful if the resolution of the data is not high
enough to reveal the clonal composition of each sample. If the assumption is violated the tree
will still represent similarities between samples, but it might differ from the true underlying
phylogenetic trajectory [4]. Sample tree methods are mainly used in the context of copy
number based phylogenies because the ability to deconvolute copy number profiles is still
limited.
In principle, classic phylogenetic methods like neighbour joining on a Euclidean distance
matrix or maximum parsimony could be used to infer sample trees. However, these methods
consider each genomic location individually and do not take into account horizontal depen-
dencies in the data, which are caused by the fact that copy number changes affect a group of
neighbouring positions at a time. Consequently, a single copy number change would yield
different distances depending on whether it is small or large. For this reason, distances that
are calculated using individual genomic locations do not reflect the real number of copy
number events and are unsuitable for inferring phylogenies from this data [148].
To account for horizontal dependencies, copy number specific approaches have been
developed. One of these is TuMult [81]. It uses the shared chromosome breakpoints between
samples to infer phylogenies. However, TuMult is restricted to a small number of samples
and uses the total copy number, discarding information from the two parental alleles [151].
An alternative approach is MEDICC [151]. In contrast to most deconvolution-based
methods, MEDICC does not rely on the infinite sites assumption, which is often violated
in copy number data due to overlapping events. Instead, it takes a minimum evolution
approach. Like many classic phylogenetic methods, it is a distance-based approach. However,
its distance measure is based on copy number events instead of single-character changes.
MEDICC takes allele-specific copy number data and infers a phylogeny that minimises the
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event distance using finite state transducers. A limitation of both TuMult and MEDICC is
that they do not account for noise in the copy number profiles.
2.3.7 Summary
In summary, many bulk sequencing approaches covering different data types, and sample
numbers exist. However, they come with important limitations.
Deconvolution-based methods rely on clustering mutations by their cellular prevalences,
but estimating cellular prevalences remains challenging due to copy number changes. Fur-
thermore, the cellular prevalences of mutation clusters often overlap, this leads to uncertainty
in the assignment of mutations to clusters and, in the worst case, can lead to clustering of
independent groups of mutations. Frequency-based clustering is especially problematic for
low-frequency mutations because their VAF estimates are noisier and because the chance
of overlapping low-frequency clusters is higher. Additionally, cluster prevalences may not
define a unique tree structure or may be phylogenetically incompatible.
Other methods aim to infer clonal genotypes directly. To overcome identifiability issues,
some of these methods rely on strong evolutionary assumptions, which go far beyond the
perfect and persistent phylogeny assumption and whose biological justification is unclear.
Other methods reduce the solution space by limiting the maximum number of inferred
subpopulations to the number of samples.
Treeomics and sample tree methods assume that mixing of subpopulations is rare or
non-existent, respectively and should, therefore, be applied with caution. Furthermore, they
require a relatively large number of samples.
2.4 Single-cell approaches
Recent advances in single-cell sequencing technologies have promised to reveal tumour
heterogeneity at a much higher resolution [107, 169, 58]. The advantage of single-cell
sequencing for phylogeny reconstruction is that it provides direct information about the
co-occurrence of mutations. However, single-cell sequencing comes with its own challenges.
The following section gives an introduction to single-cell sequencing and the types of errors
and biases that can be introduced in the process.
2.4.1 Single-cell sequencing technologies
Single cell isolation In the first step, single cells need to be isolated. Methods to do
this are micro-manipulation [179, 58, 169, 85], fluorescence activated cell sorting (FACS)
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[23], laser-capture microdissection [10, 45, 170] and microfluidics [36, 168]. Some of these
methods can introduce biases in the cell selection, which need to be taken into account in
the experimental design [48]. If cells are not separated correctly, two cells, called doublets,
may be isolated together. Genotypes inferred from doublets are a combination of the two
cells, making tree inference more difficult. Doublet rates depend on the platform used
for single-cell isolation and other experimental conditions such as cell concentration. For
Drop-Seq, which uses microfluidics for cell isolation, estimates of doublet frequencies range
from 0.36% to 11.3% [94]. Fluidigm assessed doublet rates for the C1 integrated fluidic
circuit platform across different conditions and cell types and estimated a doublet rate of 30%
(standard deviation 10%) [41]. Microscopy images can help to exclude doublets from further
analysis. However, in a study by Macosko et al. [94] only a third of the doublets could be
identified using this technique, as the majority of doublet cells are stacked on top of each
other [41].
Single cell whole genome amplification A typical cancer cell contains between 6
and 12 picograms of DNA [109]. In comparison, high-throughput sequencing requires
micrograms of DNA [141]. For this reason, the single-cell DNA needs to be amplified before
it can be sequenced. DNA amplification it is a major source of noise in single-cell sequencing
data. Noise caused by whole genome amplification (WGA) of single-cells includes
• false-positive mutations caused by amplification errors,
• false-negative mutations caused by allelic dropout events (ADO) in which one allele at
a heterozygous locus is not amplified,
• missing genotypes caused by regions without amplification and
• uneven coverage caused by amplification biases [110].
Three major WGA techniques have been used for single-cell sequencing [59] and each
of them has different advantages and disadvantages regarding technical errors.
The first technique is called degenerate oligonucleotide-primed polymerase chain reaction
(DOP-PCR) [160] and was used as part of the first single-cell DNA sequencing method,
single-nucleus sequencing [107]. DOP-PCR primers consist of random sequences at the 3’
end and a fixed sequence at the 5’ end. In the first amplification step, the primers bind to the
DNA via their random part and are extended. In the second step, the DNA fragments are
amplified by PCR using the fixed 5’ sequences. In every round of PCR, the DNA fragments
are doubled. A drawback of this exponential amplification is that small differences in the
amplification levels of different genomic regions in the early stages get exponentially enlarged
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later on, yielding over- and under-amplified regions and a single-cell genome coverage of
only about 10% [109]. Due to the low coverage, DOP-PCR is unsuitable for detecting SNVs
from single cells. However, it can be used to identify copy number aberrations in the range
of megabases and larger [59].
The second technique is called multiple displacement amplification (MDA) [26]. It
is the basis of two single-cell DNA sequencing methods, nuc-seq [58, 169] and single
nucleus exome sequencing (SNES) [83]. MDA uses random primers and amplification is
performed under isothermal conditions which enable the use of Φ29 DNA polymerase. This
polymerase is characterised by a strong strand displacement activity and a high replication
fidelity. Thereby, MDA can achieve a single-cell genome coverage of more than 90%[109]
and yields datasets with relatively low false positive rates [59]. However, like DOP-PCR,
MDA is non-linear leading to uneven coverage. In case of MDA, the amplification bias is
variable from cell to cell and the read depth can therefore not be normalised based on a
set of reference cells. For these reasons, MDA is used primarily for SNV detection from
single-cells [58, 169, 85].
The third technique, multiple annealing and looping-based amplification cycles (MAL-
BAC) [179], is an amplification technique specifically developed for single-cell DNA se-
quencing. Like DOP-PCR, it uses primers with random 3’ and fixed 5’ sequences for
pre-amplification. The primers are designed such that the 3’ and 5’ ends of the full amplicons
are complementary and can hybridise to each other. This prevents the amplicons from being
amplified further and ensures that the first stage of the amplification is quasilinear, leading
to a lower amplification bias. The pre-amplification step is followed by PCR. Advantages
of MALBAC compared to MDA are a more uniform coverage as well as a lower ADO rate.
The false positive rate, however, is higher due to the use of a different DNA polymerase
[59]. Even though MALBAC is not free from amplification bias, the bias is similar between
replicates of cells, which makes normalisation of the sequencing depth feasible. This makes
MALBAC the preferred technique for the analysis of single-cell copy-number aberrations.
Huang et al. [59] performed a comprehensive comparison of the different amplification
methods using commercially available WGA kits on diploid human cell lines. They report
ADO rates of 0.78 for DOP-PCR, 0.33 to 0.38 for MDA and 0.21 to 0.28 for MALBAC. The
corresponding false positive rates were 9.6×10−4 for DOP-PCR, 8.2×10−5 to 1.3×10−4
for MDA and 2.4× 10−4 to 3.8× 10−4 for MALBAC. Others have reported ADO rates
between 0.16 to 0.43 and false positive rates between 2.67×10−5 to 6.7×10−5 [58, 169, 85]
for MDA. In the genotype matrices produced by Li et al. [85] and Hou et al. [58] 55.2% and
57.7% of values are missing, respectively.
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In addition to the technical errors mentioned above, amplification can produce chimeric
DNA fragments, which are amplification artefacts that contain sequences from different parts
of the genome [48]. For this reason, inference of structural variants like small insertions and
deletions from single cells remains challenging.
Whole genome, exome and targeted sequencing Once amplified, the single-cell
DNA can be subjected to standard sequencing protocols used for bulk DNA including whole
genome, exome or targeted sequencing. Whole genome sequencing offers to yield most
information about the genome. However, it is also the most expensive. In the context of
single-cell sequencing it is mostly used for the analysis of copy number alterations and
shallow sequencing is used to reduce the cost [107].
Alternatively, one can restrict sequencing to selected regions of the genome using exome
or targeted sequencing. Targeted sequencing can, for example, be based on a particular set
of genes. Leung et al. [82] used 200 known cancer-associated genes in their protocol for
targeted DNA sequencing from single nuclei. The main advantage of targeted sequencing
is that it drastically reduces the cost per cell, which means that more cells can be analysed.
However, this needs to be weighed up against the size of the sequenced regions, which limits
the number of mutations that can be detected [48].
Data preprocessing Even though false positive rates (FPR) in the order of 10−4 might
seem small at first sight, the fact that the genome is extremely large means that false positives
can easily outnumber true somatic variants [89]. For the human exome alone, which contains
approximately 30 megabases [111], an FPR of 10−4 would yield around 3000 false positives.
The number of false positives is usually reduced by census-based variant calling, which
only selects variants that are observed in multiple cells. Hou et al. [58] and Xu et al. [169]
for example select the threshold t, the minimum number of cells in which a mutation needs
to occur in order to be called, such that the expected number of false positive mutation sites
is smaller than 1, i.e. they choose the smallest t that satisfies
n
∑
i=t
(
n
i
)
FPRi(1−FPR)n−i ·Sexome < 1, (2.5)
where n is the number of single cells, and Sexome is the size of the exome. However, consensus-
based variant filtering cannot remove sites of recurrent sequencing errors [108] or errors
caused by doublets. Furthermore, it implies that private mutations of single-cells cannot be
identified.
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2.4.2 Inferring trees from single-cell sequencing data
Various methods have been used to infer trees from single-cell datasets of SNVs. These
include classic phylogenetic methods as well as new heuristic and probabilistic approaches.
A summary of probabilistic single-cell phylogeny methods is shown in Table 2.2.
• Yu et al. [173] used UPGMA (Unweighted Pair Group Method with Arithmetic Mean),
whereas Xu et al. [169] applied the neighbour joining algorithm. Both are agglomera-
tive hierarchical clustering methods. Hughes et al. [60] used neighbour joining trees as
input for a likelihood optimisation method, which is based on a general time-reversible
substitution model. Another classic phylogenetic approach is Bayesian phylogenetic
inference as used by Eirew et al. [33].
• Potter et al. [127] defined subpopulations by grouping cells with identical genotypes
into clones and then applied a maximum parsimony approach. Their data sets were
derived by single-cell qPCR of few genetic markers. Their definition of subpopulations
is not suitable for noisy single-cell data with hundreds of genetic markers, where the
observed genotypes of any two cells differ. Furthermore, maximum parsimony does
not account for noise.
• Some methods first attempt to cluster cells into subpopulations and then infer minimum
spanning trees. Gawad et al. [47] do this using model-based clustering, whereas Yuan
et al. [174] use k-means and hierarchical clustering.
None of the methods mentioned so far accounts for the noise of single-cell datasets. However,
probabilistic models have started to emerge.
• Yuan et al. [174] developed a probabilistic model called BitPhylogeny. It uses a tree-
structured mixture model in combination with MCMC to cluster cells and to infer
their phylogenetic relationships. While mixture models are widely used and valuable,
they require large data sets in order to converge to an accurate representation of the
underlying distributions. Current single-cell data sets in contrast are small, containing
usually fewer than 100 cells [107, 169, 58, 85, 173, 167, 60, 89].
• Roth et al. [140] use a hierarchical Bayesian mixture model to infer clones and geno-
types. In contrast to Bitphylogeny, their method Single Cell Genotyper accounts for
doublet errors. Furthermore, they use variational Bayes for the inference. However,
their approach has only been tested on targeted sequencing data, which has different
error profiles than the more commonly used WGA-based sequencing [110].
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Table 2.2 Overview of probabilistic phylogenetic methods for single-cell sequencing data.
All of these methods use point-mutations as phylogenetic markers. ∗ddClone requires both
single-cell and bulk sequencing data.
Method Model Inference Phylogenetic representation Year Source
BitPhylogeny Tree-structured stick breaking MCMC clone tree 2015 [174]
OncoNEM custom likelihood model custom search algorithm clone tree 2016 Chapter 3
SCITE custom likelihood model MCMC mutation tree 2016 [65]
Single Cell Genotyper hierarchical Bayesian model variational Bayes clonal genotypes 2016 [140]
ddClone∗ Dirichlet process mixture model MCMC mutation clusters 2017 [144]
• Recently, Salehi et al. [144] developed ddClone. This method uses a combination of
single-cell and bulk sequencing data. It infers mutation clusters from bulk data using a
Dirichlet process mixture model, where the single-cell sequencing data serves as prior
for the mutation clusters and their prevalences.
• Kim and Simon [75] proposed a heuristic method for inferring mutation trees. These
are trees in which each node corresponds to a mutation instead of a clone. Recently,
Jahn et al. [65] developed a probabilistic version of this approach called SCITE. Since
the model behind SCITE is related to the method presented in the next chapter, it will
be discussed in more detail at the end of Chapter 3.
As with bulk-sequencing, attempts to infer phylogenies from copy number data are less
common.
• Navin et al. [107] and Wang et al. [167] used neighbour joining on Euclidean distances
to infer trees from single-cell copy-number profiles obtained by whole-genome se-
quencing. As explained in the previous section, the Euclidean distance is an unsuitable
distance measure for copy number profiles.
• Chowdhury et al. [19, 20] used Steiner trees to infer phylogenies from single-cell
copy number profiles obtained from fluorescent in situ hybridisation. Their algorithms,
however, only infer trees from low-dimensional genotype spaces.
• Garvin et al. [46] developed Ginkgo, which clusters samples using the Pearson correla-
tion as dissimilarity measure.
All in all, phylogeny inference from single cells is less advanced than inference from bulk
data and suitable methods to infer single-cell phylogenies are still lacking. Current methods
do not account for the large proportion of noise in the data or they require data sets that are
much larger than the ones currently available.
Chapter 3
Inference of single-cell phylogenies
The last chapter described current approaches to inferring tumour phylogenies from single-
cell sequencing data and their limitations. This chapter presents a new approach, OncoNEM,
to overcome these limitations (Section 3.1). The main contribution is a probabilistic model,
which accounts for the noise in single-cell data, and a heuristic search algorithm to explore
the search space. I assess the robustness of OncoNEM in simulations (Section 3.2) and
compare its performance with that of competing methods (Section 3.3), which were chosen
to be a representative selection of the approaches described in Chapter 2. Section 3.4
presents the results of applying OncoNEM in two case studies: a data set containing 44
single tumour cells from a muscle-invasive bladder transitional cell carcinoma and a data
set containing 58 single tumour cells from an essential thrombocythemia. Finally, I describe
an extension of OncoNEMs to infer mutation trees (Section 3.5) and discuss OncoNEM’s
limitations (Section 3.6). This chapter contains text and figures from Ross and Markowetz
[136].
3.1 A probabilistic model for single-cell phylogenies
3.1.1 Modelling noisy subset relationships
As described in Chapter 1 and 2, tumour evolution produces cell populations containing
different sets of mutations and, under the infinite sites assumption, the subset relationships of
the mutations describe the phylogenetic relationships between the different populations.
A probabilistic method that uses noisy subset relationships to infer graphs are Nested
Effects Models (NEMs) [99, 100]. More specifically, NEMs have been developed to infer
signalling hierarchies from the noisy measurements of gene expression changes from gene
perturbation screens.
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Fig. 3.1 Nested Effects Models in a nutshell. a − The input to NEMs is a noisy data
matrix from a gene perturbation screen. b − The signalling pathway is inferred based on
the subset structure of perturbation effects.
The input to NEMs is a matrix of a set of signalling genes (S-genes) versus a set of
effect genes (E-genes). S-genes are genes that are thought to be related through an unknown
signalling pathway. E-genes are genes whose expression levels change if one of the signalling
genes is perturbed, for example using RNAi. The matrix describes for each pair of S-genes
and E-genes if perturbing S affected the gene expression of E (Figure 3.1a). The main
assumption behind NEMs is that the genes that show an effect upon perturbation of a
particular S-gene Si will be a subset of the genes that show an effect upon perturbation of
a signalling gene that is upstream of Si (Figure 3.1b). NEMs offer a probabilistic scoring
function which uses this assumption to evaluate the fit between a given pathway model and
the observed data.
3.1.2 Inferring signalling pathways versus tumour phylogenies us-
ing NEMs
Similar to NEMs, we aim to infer a graph from noisy subset relationships. For this reason,
we used NEMs as the basis for developing OncoNEM (Oncogenetic Nested Effects Model).
OncoNEM is an automated method for reconstructing clonal lineage trees from somatic
single nucleotide variants (SSNVs) of multiple single tumour cells that exploits the nested
structure of mutation patterns of related cells. In the following sections, we will describe
OncoNEM in detail. First, however, we discuss some of the key differences between the
inference of signalling pathways from gene perturbation screens and the inference of tumour
phylogenies from single-cell single nucleotide variants.
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Inversion of subset relationships E-genes affected by downstream signalling genes are
subsets of the E-genes affected by upstream signalling genes. Those up- and downstream
subset relationships are inverted in the setting of phylogenies. As mutations accumulate over
time, populations that occurred early during tumour development will carry a subset of the
mutations that are present in their descendants.
Targeted perturbations versus random mutations In the setting of NEMs, it is known
which node in the network is perturbed due to the targeted nature of the intervention. However,
the effect of the perturbation on the pathway components cannot be observed directly.
Instead, we observe effects on downstream reporters, but the connection between the pathway
components and the reporters is unknown a priori.
In case of OncoNEMs, the perturbations are spontaneously occurring mutations, which
means that the origin of the perturbation signal is unknown a priori. However, the effect of a
perturbation on the graph components can be observed directly in the form of the single-cell
genotypes.
Graph size and structure For OncoNEMs it is not only unknown in which cell a mutation
originated, but it is also possible that a mutation originated from an ancestral tumour cell
population that is not even represented in our data set. For this reason, the size of the
oncoNEM graph is unknown a priori. The size of the inferred signalling graph, in contrast,
is defined by the number of perturbed genes. In addition to the graph sizes, the structures
also differ: Signalling pathways can have complex structures. To reflect this, NEMs infer
directed acyclic graphs. Tumour evolution is thought of as a branching process. Therefore,
OncoNEMs infer directed, arbitrary trees.
Data NEMs have been developed to handle complete data, OncoNEMs, in turn, need to
handle large amounts of missing values to be useful in practice.
3.1.3 Likelihood model of OncoNEMs
To model the accumulation of mutations, we assume that each locus gets mutated only once
(infinite sites assumption [76]) and that mutations are never lost. Under these assumptions,
direct relationships between clones imply that the mutations of the ancestral clone are a
subset of the descendants’ mutations. To define the likelihood of a tree given the observed
genotypes, OncoNEM predicts the expected mutation patterns based on the tree and then
scores the fit between predicted and observed mutations patterns while probabilistically
accounting for genotyping errors. A schematic illustration of the OncoNEM scoring model
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is shown in Figure 3.2. The derivation of the scoring function is described in the following.
It is adapted from the derivation of NEMs [99] and takes the differences mentioned above
into account.
A Clonal lineage tree
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Fig. 3.2 Toy example of the OncoNEM scoring model. A − Hypothesis of a clonal lineage
tree that describes the subpopulations of a tumour (grey circles) and their relationships
(black arrows). B − This tree can be represented as a prediction matrix that predicts
the mutation pattern we expect to see across all k cells for a mutation that occurred in
a certain clone θ . C − Assuming that we know the originating clone of every mutation
(blue lines in clonal lineage tree), we can extend the prediction matrix to a full matrix of
expected genotypes. D − To score the tree, expected genotypes are compared to observed
genotypes. The more mismatches (FP: false positive, FN: false negative) there are, the
lower the likelihood of the tree given the data. Since the origin of a mutation is unknown a
priori, the full likelihood of the lineage tree is calculated by marginalising over all possible
origins for every mutation.
Data We assume that the variants of the single cells have already been called and filtered
so that the data set only contains the somatic variant sites. Let D = (dkl) be the matrix of
observed genotypes where k ∈ {1, . . . ,n} is the label of a single cell and l ∈ {1, . . . ,m} is
the index of a mutation site. Let dkl ∈ {0,1,NA} denote the mutation status of cell k at site l,
where 0, 1 and NA encode an unmutated, mutated or unknown site, respectively.
Clonal lineage trees We assume that a clonal lineage tree is a directed, not necessarily
binary tree T whose root is the unmutated normal. Every node of this tree represents a clone
c ∈ {1, . . . ,N} that contains zero, one or multiple cells of the data set. Let c(k) denote the
clone that contains cell k. In the following, we assume without loss of generality that the
root has index 1.
OncoNEM An OncoNEM has two parts: the clonal lineage tree T and the occurrence
parameter Θ= {θl}ml=1, where θl takes the value c of the clone where mutation l originated.
The core of our method is a function that defines the probability of the OncoNEM given
a data set D and is derived in the following. Using a Bayesian approach, the posterior
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probability of T and Θ given D can be written as
P(T ,Θ|D) = P(D|T ,Θ)P(Θ|T )P(T )
P(D)
. (3.1)
The model prior P(T ) can be used to incorporate prior biological knowledge. We assume
it to be uniform over the search space. The normalising factor P(D) is the same for all models
and not necessary to compute when comparing them. Therefore,
P(T ,Θ|D) ∝ P(D|T ,Θ)P(Θ|T ). (3.2)
Likelihood for known Θ Let us assume that we know for each locus l in which clone the
mutation occurred and that no mutations occur in the normal. This is equivalent to restricting
the parameter space of θl to {2, . . . ,N} and is justified by stringent variant filtering of the
input data.
Given T and Θ, we can predict the genotype of every cell: if c is the clone in which a
mutation occurred, the mutation is present in c and all descendants of c and absent in all
other clones, i.e. given θl = c, the tree determines the predicted genotype δkl .
Finally, to calculate the likelihood of (T ,Θ), we compare the expected genotypes with
the observed ones. We model the genotyping procedure as draws of binary random variables
ωkl from the sample space Ω= {0,1} and assume that, given T and Θ, the random variables
are independent and identically distributed according to the probability distribution
P(ωkl|δkl) =
(
P(0|0) P(1|0)
P(0|1) P(1|1)
)
=
(
1−α α
β 1−β
)
, (3.3)
where α and β are global probabilities of false positive and false negative draws, respectively.
We interpret the observed genotypes dkl as events from the event space P(Ω) =
{ /0,{0},{1},{0,1}}, where a missing value corresponds to the event {0,1}. Then, the
probability of the observed genotypes D given T and Θ is
P(D|T ,Θ) =
m
∏
l=1
P(Dl|T ,θl) =
m
∏
l=1
n
∏
k=1
P(ωkl ∈ dkl|δkl), (3.4)
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where
P(ωkl ∈ dkl|δkl) =

1−α if dkl = {0} and δkl = 0
α if dkl = {1} and δkl = 0
β if dkl = {0} and δkl = 1
1−β if dkl = {1} and δkl = 1
1 if dkl = {0,1}
(3.5)
is the probability of a single observation given the predicted genotype.
Likelihood for unknown Θ So far we assumed Θ to be known, but this is generally not
the case. To derive the likelihood of the entire data matrix, we treat Θ as a nuisance parameter
and marginalise over it. Furthermore, we make two assumptions: First, the occurrence of
one mutation is independent of the occurrence of all other mutations, i.e.
P(Θ|T ) =
m
∏
l=1
P(θl|T ), (3.6)
and second, the prior probability of a mutation to occur in a clone is
P(θl = c|T ) =
0 if c is the normal (c = 1),1
N−1 otherwise.
(3.7)
Then the marginal likelihood is
P(D|T ) =
∫
P(D|T ,Θ)P(Θ|T )dΘ
=
m
∏
l=1
∫
P(Dl|T ,θl)P(θl|T )dθl
=
1
(N−1)m
m
∏
l=1
N
∑
c=2
n
∏
k=1
P(ωkl ∈ dkl|T ,θl = c)
=
1
(N−1)m
m
∏
l=1
N
∑
c=2
n
∏
k=1
P(ωkl ∈ dkl|δkl) .
(3.8)
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3.1.4 Algorithms for OncoNEMs inference
The search space of cell lineage trees with n nodes contains nn−2 models [155], making
exhaustive enumeration infeasible for trees with more than nine nodes. This is further
complicated by the fact that the size of the tree is not known a priori due to unobserved
subpopulations.
To address these challenges and to identify high-scoring models in the space of possible
tree structures, we developed a sequence of three inference algorithms.
We start with an initial search, where we restrict the model space to cell lineage trees, i.e.
trees where each node corresponds to a single cell. This yields a first estimate of the tree. The
second step tests whether adding unobserved clones to the tree substantially increases the
likelihood. This is to identify ancestral subpopulations that are not represented in the single
cell sample. The third step yields the final model of the clonal lineage tree by clustering cells
within the previously derived tree into clones. An overview of the inference steps is shown in
Figure 3.3 and details of the algorithms are described in the following sections.
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Fig. 3.3 Toy example of OncoNEM inference steps. Given the observed genotypes and
the input parameters α and β , the log-likelihood of the start tree, which is by default a
star-shaped tree, is −47.61. In the first step of the initial search, all neighbours of the
star tree are scored. The highest scoring tree obtained in this step has a log-likelihood of
−34.26. In this toy example, the highest scoring tree of the first step is also the best cell
lineage tree, overall. Therefore, the initial search terminates with this tree as solution. In
the first refinement step, we find that inserting an unobserved node into the branch point
of our current tree increases the log-likelihood by 3.82. Since this improvement is larger
than the Bayes factor threshold of 2.3, the solution with the unobserved clone is accepted.
In the final refinement step, cells are clustered along edges. In the toy example, only one
clustering step does not decrease the log-likelihood by more than log(ε).
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Step 1) Initial search: Building a cell tree
The initial search algorithm performs a local heuristic search and is based on two lists
containing trees:
a) The list of scored trees. This list contains all trees which have been scored already.
b) The priority queue. This list contains all trees which have been scored at some point
during the search but whose neighbours have not yet been scored explicitly.
Both lists are ordered by the likelihood of the trees as defined in Section 3.1.3, with the tree
with the highest likelihood coming first.
By default, the search starts with a tree that has a star topology, i.e. a tree where all cells
are attached to the normal root. We score the start tree and add it to both the priority queue
and the list of scored trees. We pick the highest scoring tree from the priority queue list and
generate all of its neighbours. Each neighbour is scored and added to both lists, unless it is
already on the list of scored trees, in which case we do nothing. This step is repeated until
the highest scoring tree has not changed for more than δ generations, where δ is a parameter
set by the user. For a detailed description of the algorithm see Algorithm 1.
Unlike hill climbing [86], which only considers the neighbourhood of its current best
solution and can therefore easily get stuck in local optima, our algorithm uses the highest
scoring tree in the priority list as a starting point for the next search step. This tree does not
have to be a neighbour of the current best solution and also does not have to have a higher
score than the current best solution. To prevent the algorithm from reanalysing solutions,
each tree can only be scored and added to the priority queue once.
Step 2) Refinement: Testing for unobserved clones
The number of sequenced single cells is usually small compared to the tumour size. Conse-
quently, some clones of the tumour may not be represented in the single cell sample. This
problem is similar to the ‘unknown unknowns’ problem in reconstructing biological pathways
[142], where latent variables which cause additional patterns in the observed data set can be
inferred. In the OncoNEM setting, unobserved clones with at least two child clones create
additional mutation patterns and can therefore potentially be inferred (Figure 3.4). OncoNEM
accounts for this possibility by testing if there is a lineage tree with additional, unobserved
branch nodes that can better explain the observed data (see Algorithm 2). Unobserved clones
that connect observed clones linearly cannot be inferred, but also do not change the shape of
the tree.
To test for unobserved clones, the algorithm identifies all branch points of the tree inferred
in step 1. For each branch point, it then generates a new tree by inserting an unobserved
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Algorithm 1: Heuristic search algorithm. D is the genotype Matrix, α and β are the
error rates and startTrees is the list of trees the heuristic search is started from. The
algorithm terminates if the highest scoring solution has not changed for more than δ
iterations.
1 Function heuristicSearch(D, α , β , startTrees, δ)
2 initialize scoredTrees ← empty;
3 initialize priorityQueue ← empty;
4 initialize counter ← 0;
5 for tree in startTrees do
6 score tree;
7 add tree to scoredTrees;
8 add tree to priorityQueue;
9 end
10 bestTree ← scoredTrees[1];
11 while counter ≤ δ do
12 currentTree ← priorityQueue[1];
13 delete currentTree from priorityQueue;
14 for every neighbour of currentTree do
15 if neighbour /∈ scoredTrees then
16 score neighbour;
17 add neighbour to scoredTrees;
18 add neighbour to priorityQueue;
19 end
20 end
21 if bestTree ̸= scoredTrees[1] then
/* Highest scoring solution changed */
22 counter ← 0;
23 bestTree ← scoredTrees[1];
24 else
25 counter ← counter +1;
26 end
27 end
28 return scoredTrees[1]
29 end
node into this point. The collection of these trees are used as start trees in a new search that
optimises the position of the unobserved node in the tree. A larger model is accepted if the
Bayes factor of the larger versus the smaller model is greater than a threshold ε (see below).
If the larger model passes the threshold, these expansion steps are repeated. Otherwise, the
algorithm terminates with the smaller solution.
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Algorithm 2: Expansion algorithm − tests for unobserved clones. Tn represents the
cell lineage tree with n nodes inferred by the initial heuristicSearch(), ε is the
Bayes factor threshold. As before, D is the genotype Matrix, α and β are the error
rates and δ defines the termination criterion for the heuristic search.
1 Function expandTree(D, α , β , Tn, δ , ε)
2 initialize i← 0;
3 repeat
4 i← i+1;
/* Generate start trees */
5 startTrees ← star tree with n+ i nodes;
6 branchPoints ← vector of nodes in Tn+i−1 that have at least two children;
7 for j in branchPoints do
8 Generate a new tree by inserting an unobserved node into j;
9 Add tree to startTrees;
10 end
11 scoredTrees ← heuristicSearch(D, α , β , startTrees, δ);
12 Tn+i ← highest scoring tree in scoredTrees in which every unobserved node
has at least two children;
/* Calculate Bayes factor */
13 K ← P(D|Tn+i)/P(D|Tn+i−1)
14 until K < ε;
15 return Tn+i−1
16 end
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Fig. 3.4 Unobserved clones lead to differences between observed and predicted mutation
patterns. To explain the observed mutation patterns the model shown in (A) treats positions
3 and 4 as false negatives in clone A or false positives in clone B and C. Alternatively, we
can explain the data without observational errors by adding an intermediate unobserved
clone X as shown in (B).
Step 3) Refinement: Clustering cells into clones
The clustering procedure tests if the data can be explained better or equally well by a clonal
lineage tree in which multiple cells correspond to the same node (see Algorithm 3). Nodes are
clustered iteratively along branches until merging cells into clones decreases the likelihood
by more than a factor of 1/ε compared to the best clustering solution found so far. Cells may
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be clustered into clones because they are genetically very similar or because of the limited
information content of the data, which can be due to genotyping errors, missing values or a
restricted number of SSNVs in the sequenced regions of the genome.
Algorithm 3: Clustering algorithm. Tstart represents the cell lineage tree inferred by
expandTree(). As before, D is the genotype Matrix, α and β are the error rates
and ε is the Bayes factor threshold.
1 Function clusterTree(D, α , β , Tstart, ε)
2 initialize T ←Tstart ; /* Current tree */
3 initialize T ∗←Tstart ; /* Best tree scored so far */
4 repeat
5 for every edge ei do
6 Generate clustered tree Tei from T by merging the clones connected by ei;
7 end
8 Te∗i ← argmax
Tei
P(D|Tei);
9 K ← P(D|T ∗)/P(D|Te∗i );
10 if K ≤ ε then
/* Accept clustering solution */
11 T ←Te∗i ;
12 if P(D|T ∗)< P(D|Te∗i ) then
/* Save clustering solution as new best tree */
13 T ∗←Te∗i ;
14 end
15 end
16 until K > ε;
17 return T
18 end
Choosing the Bayes factor threshold ε
Choosing the parameter ε is a trade-off between inferring distinct clones with little support
from the data and overly strict clustering. In this setting, choosing ε > 1 means that we
prefer the smaller model unless the strength of evidence for the larger model compared to the
smaller one exceeds a certain threshold. Jeffreys’ [66] or Kass and Raftery’s [73] scale for
the interpretation of the Bayes factor can be used as guidance. We used a value of ε = 10,
which denotes strong evidence according to Jeffreys’ scale.
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Estimating the occurrence parameter Θ
Given a lineage tree, we can estimate which clones acquired which mutations during tumour
development. To do this, we calculate the posterior probability of a mutation having occurred
in clone c. Using a uniform prior for the occurrence parameter θl ∈ {2, . . . ,N}, we obtain
P(θl = c | T ,D) = 1Z
n
∏
k=1
P(ωkl ∈ dkl | T ,θl = c) , (3.9)
with normalising constant
Z =
N
∑
c=2
n
∏
k=1
P(ωkl ∈ dkl|T ,θl = c) . (3.10)
The branch lengths L of the tree can be estimated as the expected number of mutations
that separate a clone c from its parent pa(c),
Lpa(c),c =
m
∑
l=1
P(θl = c|T ,D). (3.11)
Estimating model parameters α and β
Previous studies have estimated FPRs and ADO rates from the sequencing data [169, 58].
These error rates are, however, not equivalent to the false positive and false negative parame-
ters α and β used by OncoNEM. This is due to two reasons (i) the pre-processing steps that
are applied to the sequencing data to generate the final genotype matrix and (ii) doublets.
Effect of pre-processing on error parameters The FPR estimated in sequencing studies
is usually the number of false variants per sequenced base pair
FPR =
∑k∑l∈L1dkl=1∧δkl=0
n|L| , (3.12)
where dkl and δkl are the observed and true genotype at site l and in cell k, respectively, and
L is the set of all sequenced sites. Let Li ⊂ L be the set of sites for which mutations have
been observed in i cells. As L0,L1, . . . ,Ln form a partition of L, the FPR can be expressed as
FPR =
∑k
(
∑l∈L0 1dkl=1∧δkl=0+∑l∈L1 1dkl=1∧δkl=0+ . . .+∑l∈Lk 1dkl=1∧δkl=0
)
n(|L0|+ |L1|+ . . .+ |Ln|)
=
∑k
(
∑l∈L1 1dkl=1∧δkl=0+ . . .+∑l∈Lk 1dkl=1∧δkl=0
)
n(|L0|+ |L1|+ . . .+ |Ln|) .
(3.13)
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To obtain the genotype matrix which is used as an input to OncoNEM, uninformative sites
that show no mutations across all cells are removed, i.e. only sites l ∈ L1 ∪ . . .∪ Lk are
selected. In this case the false positive parameter α is
α =
∑k
(
∑l∈L1 1dkl=1∧δkl=0+ . . .+∑l∈Lk 1dkl=1∧δkl=0
)
n(|L1|+ . . .+ |Lk|) . (3.14)
Given that most of the sites sequenced will not show a mutation, |L0| will be large, which
means that the estimated FPR will be much lower than α . If a consensus-based variant
filtering threshold t is applied, only mutations that are observed in at least t cells are selected
and α is changed further to
α =
∑k
(
∑l∈Lt 1dkl=1∧δkl=0+ . . .+∑l∈Lk 1dkl=1∧δkl=0
)
n(|Lt |+ . . .+ |Lk|) . (3.15)
While α will be lower for a consensus filtered data set than α in equation 3.14, the exact
effect of this step is difficult to estimate.
The impact of filtering is not limited to α but affects the false negative parameter β ,
as filtering removes sites that have a high ADO rate preferentially. Furthermore, the data
matrix is binarised as part of the pre-processing. In this step, all homozygous mutant sites are
interpreted as heterozygous normal/mutant. This step reduces the false negative rate (FNR)
by approximately half and further explains why β is expected to differ from the genome-wide
estimate of the ADO rate.
Effect of doublets on error parameters Sequencing doublets can create mutation
patterns that are incompatible with a tree structure. These mutation patterns further increase
the number of false positives and false negatives that are needed to explain the data. At the
same time, these mutation patterns are not caused by sequencing errors in the strict sense, as
they are present in the original DNA.
While all of the points discussed above are expected to change the error rates of the final
dataset, the exact impact on the parameters is difficult to estimate. Therefore, we chose to
estimate error rates for our model directly from the data.
We treat the selection of model parameters as part of the learning problem and estimate
them using a maximum likelihood approach, similar to Zeller et al. [177]. We create a grid of
parameter combinations α and β and optimise T given these parameters using the heuristic
search algorithm. Then, we choose the parameter combination that yields the highest scoring
tree and infer a clonal lineage tree as described above.
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This parameter estimation process is computationally expensive compared to the tree
inference. However, it can easily be parallelised, and the grid of parameter combinations can
be coarse as OncoNEM is robust to changes in the model parameters around the optimum
(see simulation results). Furthermore, the range of tested parameter combinations can be
reduced in the presence of prior knowledge.
3.1.5 Implementation
OncoNEM is freely available as an R package on Bitbucket [134] under a GPL3 license. The
user functions and the tree refinement algorithms have been implemented in R [130] whereas
the computationally expensive search algorithm has been implemented in C++ and integrated
into R using the package Rcpp [32].
3.2 Validation through simulations
We performed comprehensive simulations to assess the robustness of OncoNEM to errors
in the parameter estimates and compared its performance to six baseline methods. For
these simulation studies, datasets were created in a two-step procedure that consists of (i)
generating a tree structure and (ii) simulating the corresponding genotypes.
Simulating clonal lineage trees. To simulate a tree with c clones, we select clone one
to be the root and the parent of the second clone. Then, the remaining clones are added
iteratively by choosing a non-root node that is already part of the tree with uniform probability
as parent.
In the case of simulating trees with unobserved clones, we count how many nodes in the
simulated tree have at least two children. If this number is greater than or equal to the desired
number of unobserved clones cu, we randomly choose cu of these nodes as unobserved clones.
Otherwise, a new tree is simulated. Next, we assign one cell to every observed clone. For the
remaining cells, clones are chosen iteratively with a probability proportional to the current
clone size, to generate clones of different sizes.
Simulating genotype observations. For every mutation site, we choose the occurrence
parameter θl with uniform probability from all non-root nodes. GivenΘ and the tree structure,
the full matrix of true genotypes is obtained by setting an entry to 1 if the mutation occurred in
a clone that is ancestral to the cell’s clone or if the mutation occurred in the clone containing
the cell itself, and 0 otherwise.
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Observed genotypes are derived from true genotypes by (i) setting a fraction pmissing of
randomly chosen values to NA, (ii) setting a fraction α of unmutated, non-missing entries to 1
and (iii) setting a fraction β of mutated, non-missing entries to 0. If this yields sites without
any observed mutations, we add, for each of these sites, a false positive to a randomly chosen
cell. Finally, we randomise the order of cells in the matrix of observed genotypes, to avoid
bias in the method testing.
OncoNEM is robust to changes in error parameters α and β To test if our method
can infer the main model parameters, α and β , and to evaluate the robustness of our method
to errors in those estimates, we simulated a tree containing 10 clones, 2 of which were
unobserved, with a total number of 20 cells. A corresponding genotype matrix with 200
SNVs was simulated using an α of 0.2, a β of 0.1 and 20% of missing values. Then, we
inferred clonal lineage trees as described above, using various combinations of false positive
and false negative rates, and compared the inferred trees to the ground truth. As Figure 3.5A
shows, a large range of parameter combinations yield solutions that are close to the original
tree in terms of pairwise cell shortest-path distance and V-measure with both the inferred and
the ground truth parameters lying in the middle of this range. Similar results were obtained
on a second data set that was simulated using a much lower α of 10−5 (see Figure A.1).
These results demonstrate that OncoNEM is robust to changes in the model parameters.
OncoNEM estimates model parameters accurately In the second simulation study,
we further assessed the parameter estimation accuracy of OncoNEM. To generate different
test data sets, we varied simulation parameters such as noise levels, number of cells, number
of mutation sites, number of clones, fraction of missing values and the number of unobserved
clones.
For the case of unknown error rates, we compared the estimated FPR and FNR to the
ground truth parameters. As shown in Figure 3.5B, the estimated parameters are close to the
ground truth parameters for all but the single clone case. This demonstrates that OncoNEM
estimates model parameters accurately over a wide range of simulation settings.
OncoNEM is robust to changes in ε Next, we assessed the sensitivity of OncoNEM
to changes in the Bayes factor threshold ε . We applied OncoNEM to each simulated data
set described in the previous section, using various values for ε and recoded the inferred
number of clones (see Figure 3.6). In all simulation scenarios the number of clones is largely
independent of ε , unless this parameter is set to very low values (ε < 5). Throughout all
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Fig. 3.5 Parameter estimation. A − Dependence of OncoNEM results on inference
parameters. Log Bayes factor of highest scoring model inferred with given parameter
combination relative to highest scoring model overall. The inferred parameters (αˆ = 0.22,
βˆ = 0.08) are close to the ground truth (α = 0.2, β = 0.1). A large range of parameter
combinations around the ground truth parameters yield solutions close to the ground truth
tree in terms of pairwise cell shortest-path distance and V-measure. The distance was
normalised to the largest distance observed between any inferred tree and the ground
truth. B − Parameter estimation accuracy. FPRs and FNRs estimated by OncoNEM for
various simulation settings with five replicates each. The blue lines mark the ground truth
parameters. The grey lines mark the grid values over which FPR and FNR were optimised.
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Fig. 3.6 Dependence of OncoNEM’s clustering solution on Bayes factor threshold ε . This
figure shows the V-measure and the number of clones of the OncoNEM solution as a
function of epsilon for various simulation scenarios. Every line corresponds to one data set
of the method comparison study. Lines are colour coded by parameter setting for the varied
simulation parameter. The following settings were used as default parameters: 20 cells,
10 clones, FNR 0.1, FPR 0.2, 20% missing values, 200 mutation sites and 2 unobserved
clones. In all simulation scenarios the number of clones is largely independent of ε unless it
is set to be unreasonably small (ε < 5). The threshold ε used throughout the simulation
and case studies is 10 (dashed line), and thus well within the stable range.
further simulation and case studies ε was kept constant at 10, which is well within the stable
range.
3.3 Method comparison
3.3.1 Competing methods
Finally, using the same simulated data as above, we compared the performance of OncoNEM
in case of known and unknown inference parameters to the performance of the six baseline
methods. As representatives of classic phylogenetic methods we used likelihood optimisation
of neighbour joining trees, as applied by Hughes et al. [60], and Bayesian phylogenetic
inference, as used by Eirew et al. [33]. Both methods yield solutions where each cell
corresponds to a different leaf in the tree. This type of tree is not directly comparable to the
simulated one. To at least be able to evaluate the clustering solutions of the two methods,
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we identified subpopulations of cells within these trees by hierarchical clustering of the
trees’ distance matrices with Silhouette score-based model selection. As representatives of
hierarchical clustering based methods and the approaches used by Gawad et al. [47] and
Yuan et al. [174], we used hierarchical and k-centroids clustering with Silhouette score-based
model selection and subsequent minimum spanning tree construction. Furthermore, we
compared our method to BitPhylogeny [174] and a method for inferring mutation trees by
Kim and Simon [75].
For all but Kim and Simon’s method, clustering performance was assessed using the
V-measure, whereas the overall tree reconstruction accuracy was measured using the pairwise
cell shortest-path distance. Both measures are described in the next section. Since Kim
and Simon’s method neither infers the position of the sequenced cells within the tree nor
performs any clustering, V-measure and single cell shortest-path distance cannot be used to
assess its performance. Instead, we calculated the accuracy of the inferred mutation orders.
3.3.2 Tree comparison measures
Measuring the accuracy of mutation orders
We define the mutation order accuracy of a tree T1 given the ground truth tree T2 as the
average of
• the fraction of correctly inferred pairwise mutation orders, i.e. the probability that
mutation a is upstream of mutation b in T1 given that a is upstream of b in T2, and
• the fraction of correctly inferred mutually exclusive mutations, i.e. the probability that
two mutations a and b lie on separate branches in T1 given that a and b lie on separate
branches in T2
for all mutations that belong to different clusters in T2.
Measuring clustering performance
Clustering performance was assessed using the V-measure [133], an entropy-based cluster
evaluation measure that is calculated as the harmonic mean of the completeness and ho-
mogeneity scores of the clustering solution, where the completeness score measures the
success of including all cells of a certain subpopulation in a cluster and the homogeneity
score measures the success of including only cells from the same subpopulation in a cluster.
The V-measure takes values from 0 to 1, with higher values indicating better performance.
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Measuring tree distances
Yuan et al. [174] developed the consensus node-based shortest-path distance to compare
trees of clonal evolution, but this distance only takes nodes into account that appear in all
trees that are being compared.
In order to take all of the observed nodes into account, we developed a distance measure
called pairwise cell shortest-path distance (see Figure 3.7). This measure calculates the
distance between two trees which are built on the same set of cells but may contain a differing
number of nodes (clones). Briefly, for every pair of cells i and j, we compute the shortest-path
di j(·) between the two cells in each tree. If the two cells belong to the same clone, their
shortest-path distance is 0. Otherwise, the shortest-path distance equals the number of edges
(regardless of direction) that separate the clones of the two cells. Finally, we sum up the
absolute differences between the shortest-path distances of all unordered pairs of cells in the
two trees to obtain the overall pairwise cell shortest-path distance. A formal definition of this
distance and a proof that it defines a metric is provided in the following.
Definition of pairwise cell shortest-path distance Let T1 and T2 be two trees on the
same set of cells 1, . . . ,n in which all leaf nodes contain at least one cell. In order to mark the
root and to ensure that every node of the tree is taken into account in the distance measure,
we add an extra cell with index 0 to the root. For two cells i and j in 0, . . . ,n, let di j(T ) be
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the number of edges separating the clones c(i) and c( j) in tree T . With this we define the
pairwise cell shortest-path distance between two trees T1 and T2 as
d(T1,T2) =
n−1
∑
i=0
n
∑
j=i+1
|di j(T1)−di j(T2)|.
In order to show that this distance is a metric, we first prove the following lemma.
Lemma If di j(T1) = di j(T2) for ∀ i, j ∈ {0, . . . ,n}, then T1 =T2.
Proof We prove this by showing that, if di j(T1) = di j(T2) for all i, j in 0, . . . ,n, we can
define a bijection φ : V (T1) 7→V (T2) that maps the vertices of T1 to T2 so that
(I) cell i is in clone v j in tree T1 ⇔ cell i is in clone φ(v j) in tree T2 and
(II) vi = pa(v j)⇔ φ (vi) = φ
(
pa(v j)
)
, where pa(v j) is the parent of node v j.
We construct the bijection in several steps.
(I) Assignment of observed clones.
The distance matrix uniquely defines the observed clones of a tree: Two cells i and j
belong to the same clone if and only if di j(T ) = 0. From this it follows that two trees
with the same cell distances contain the same observed clones, i.e. we can define a
bijection φ between the observed clones of T1 and T2.
(II) Parent-child relationships between observed clones.
Let i and j be two cells in separate clones of T1, i.e. c(i) ̸= c( j). Then, c(i) = pa(c( j))
if and only if
(i) di j(T ) = 1 and
(ii) d0 j(T ) = d0i(T )+1.
Since the pairwise cell distances are equal in both trees, φ preserves the parent-child
relationships between observed clones.
(III) Assignment of unobserved clones.
Let vi be an unobserved clone of T1. Then vi has an observed descendant v j ∈ T1,
since all leaf nodes of T1 contain at least one cell by the definition of the pairwise cell
shortest-path distance. We call vi the n-th ancestor of v j. Since the distances from the
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root to v j in T1 and to φ(v j) in T2 are the same, respectively, we can assign φ(vi) as
the n-th ancestor of φ(v j).
This is a well-defined function as the assignment does not depend on the specific
choice of the descendant v j. To see this, choose another observed descendant v¯ j. Then
vi is the n¯-th ancestor of v¯ j. The distances d0v j(T1), d0v¯ j(T1) and dviv j(T1) uniquely
determine the length of the branches connecting the three nodes via vi. Since those
distances are the same in T2 it follows that the n-th ancestor of φ(v j) is the same node
as the n¯-th ancestor of φ(v¯ j).
This function defines a bijection between the vertices since the same construction from
T2 to T1 defines an inverse.
(IV) General parent-child relationships.
Assuming that vi = pa(v j) we consider the following cases to show that φ(vi) =
pa(φ(v j)):
(i) vi and v j observed – see step (II).
(ii) vi = pa(v j) and vi unobserved
Assign φ(vi) following step (III) as first ancestor of φ(v j). Then φ(vi) =
pa(φ(v j)).
(iii) vi = pa(v j), vi observed and v j unobserved
Choose vk so that it is an observed descendant of v j. Assign φ(v j) following step
(III). Then φ(v j) is the n-th ancestor of φ(vk) and φ(vi) is the (n+1)-th ancestor
of φ(vk), so that φ(vi) = pa(v j).
(iv) vi = pa(v j) and both unobserved
Choose vk so that it is an observed descendant of v j. Assign φ(vi) and φ(v j)
following step (III). Then φ(v j) is the n-th ancestor of φ(vk) and φ(vi) is the
(n+1)-th ancestor of φ(vk), so that φ(vi) = pa(v j).
The same construction from T2 to T1 defines the inverse of φ . Therefore, vi =
pa(v j)⇔ φ (vi) = φ
(
pa(v j)
)
.
With this, we can show that d(T1,T2) satisfies all the requirements of a metric.
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Proof that pairwise cell shortest-path distance is a metric
(I) Non-negativity: d(T1,T2)≥ 0
Non-negativity follows from defining the distance as a sum of absolute values.
(II) Coincidence axiom: d(T1,T2) = 0 if and only if T1 =T2
(i) If T1 =T2, then d(T1,T2) = d(T1,T1) = 0.
(ii) If d(T1,T2) = 0, then T1 =T2 as shown in the lemma.
(III) Symmetry: d(T1,T2) = d(T2,T1)
Symmetry follows from |di j(T1)−di j(T2)|= |di j(T2)−di j(T1)|.
(IV) Triangle inequality: d(T1,T3)≤ d(T1,T2)+d(T2,T3)
The usual triangle inequality for real numbers implies that
|di j(T1)−di j(T3)| ≤ |di j(T1)−di j(T2)|+ |di j(T2)−di j(T3)|.
Hence for the pairwise cell shortest-path distance we find
d(T1,T3) =
n−1
∑
i=0
n
∑
j=i+1
|di j(T1)−di j(T3)|
≤
n−1
∑
i=0
n
∑
j=i+1
|di j(T1)−di j(T2)|+
n−1
∑
i=0
n
∑
j=i+1
|di j(T2)−di j(T3)|
= d(T1,T2)+d(T2,T3).
3.3.3 Results
The results of the method comparison are shown in Figure 3.8. OncoNEM substantially
outperforms the other methods for all simulation scenarios but the single clone case. It
consistently yields results that have a smaller distance to the ground truth and a higher
V-measure than the baseline methods or, in the case of oncogenetic trees, infers the order
of mutation with a much higher accuracy. Overall, OncoNEM’s performance in the case of
unknown model parameters is comparable to its performance with given parameters.
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Fig. 3.8 OncoNEM performance assessment. A − Performance comparison of OncoNEM
and five baseline methods. Shown are the distance and V-measure of inferred trees to
ground truth. Results of single simulations are marked by dots and coloured by method,
while black horizontal bars indicate the mean over five simulations for each method. The
distances shown were normalised for the number of cells n in the trees and were obtained
by dividing the pairwise cell shortest-path distances by n(n−1)/2. Distances could only be
calculated for three of the baseline methods. Values of the varied parameters are shown in
the panels at the top. As default parameters, we used an FNR of 0.1, an FPR of 0.2, 200
sites, 10 clones, no unobserved clones, 20 cells and 20% of missing values. B − Performance
comparison of OncoNEM and Kim and Simon’s oncogenetic tree method. Shown is the
mutation order accuracy of the inferred trees for each of the simulated datasets. This
measure is undefined for datasets without mutually exclusive mutations. Therefore, no
values are shown for the single clone case and the first replicate of the 5 clone scenario, for
which the simulated tree is linear.
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3.4 Case studies
3.4.1 Analysis of a muscle-invasive bladder transitional cell carci-
noma
We used OncoNEM to infer the evolutionary history of a muscle-invasive bladder transitional
cell carcinoma previously analysed by Li et al. [85], who performed single-cell exome
sequencing of 44 tumour cells, as well as exome sequencing of normal and tumour tissue.
Li et al estimated the average ADO rate to be 0.4 and the FPR to be 6.7×10−5. Using a
census-filtering threshold of 3, they identified 443 SSNVs across the 44 cells. In their final
genotype matrix, 55.2% of the values were missing.
We binarised the genotype matrix by setting homozygous normal sites to 0 and hetero-
or homozygous mutant sites to 1 and applied OncoNEM as described above. The resulting
tree is shown in Figure 3.9b. The single linear branch from the normal suggests that all
cells in the data set are descendants of a single founder cell. The tree contains three major
subpopulations. The least mutated of these subpopulations carries about a quarter of the
detected mutations. These trunk mutations are shared by almost all of the analysed cells.
This early clone gave rise to multiple divergent subpopulations two of which are large and
again diversified into smaller subclones.
These results agree with the results of Li et al. who inferred three main subpopulations
(A, B, C) with B and C having evolved from A. Mapping the clone labels of Li et al. onto
the OncoNEM tree shows, however, that the assignment of cells to clones differs between
the two approaches (see Figure 3.10). Li et al. also inferred the origins of 8 mutations in
7 genes that are commonly altered in muscle-invasive bladder transitional cell carcinomas.
A comparison of their results with the posterior probability of θ inferred by OncoNEM is
shown in Table 3.1. The assignment of mutations to clones agrees in 7 out of 8 cases.
OncoNEM estimated the FPR to be 0.185 (see Figure 3.9a). This error rate is higher
than the expected value under the binomial model used for consensus filtering by Li et al.,
which suggests that there might be recurrent sequencing errors in the dataset. The FNR was
estimated to be 0.08. This estimated value lies within the expected range of less than half
the estimated ADO rate. See the parameter estimation section within the Methods for an
explanation of the conceptual differences between the original error rates estimated by Li et
al and the OncoNEM parameters.
To test the robustness of our results, we inferred trees using model parameters that are
slightly different from the estimated ones (see Figure A.2). The structure and the overall
features of the resulting trees are close to the original estimate, which further supports our
results.
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a b
Fig. 3.9 Results inferred by OncoNEM from bladder cancer dataset. a − The estimated
error rates are α = 0.185 and β = 0.08. b − The inferred tree suggests a branching
evolution with three major subpopulations.
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Fig. 3.10 Mapping of clone labels assigned by Li et al. [85] onto cells in oncoNEM tree.
Comparison of clone labels between the two trees shows that the assignment of cells to
clones differs between oncoNEM and the results by Li et al.
Impact of loss of heterozygosity on inference results The OncoNEM model assumes
that mutations are never lost. Deletions that lead to loss of heterozygosity (LOH) are however
common in various types of cancer.
We expect that our algorithm is able to infer good solutions despite LOH events, as long
as the fraction of mutations affected by LOH is relatively small. In this case, LOH-affected
sites will simply contribute to the error rates of false positives and false negatives, depending
on whether the deletion occurred early or late after the original occurrence of the SNV.
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Table 3.1 Comparison of origin of mutations inferred by OncoNEM with origins
inferred by Li et al. Posterior probabilities of θ inferred by OncoNEM for the eight
recurrently mutated genes analyzed by Li et al. A, B and C denote the clones inferred
by Li et al, 1 to 14 denote the clones inferred by OncoNEM. Visual comparison of the
OncoNEM tree with the phylogeny inferred by Li et al suggests that clone A corresponds to
clones 1−3, clone B corresponds to clones 4−7 and clone C corresponds to clones 10−13.
Overall, both methods assign mutations to the same clones. KIAA19581 denotes mutation
at chromosome 9, position 114376732. KIAA19582 denotes mutation at chromosome 9,
position 114376902.
1 2 3 4 5&7 6 10 11&12 13 8,9&14
A NIPBL 0.33 0.33 0.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00
CFTR 0.45 0.45 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00
DHX57 0.45 0.45 0.09 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ASTN1 0.25 0.25 0.51 0.00 0.00 0.00 0.00 0.00 0.00 0.00
B ATM 0.00 0.00 0.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00
C COL6A3 0.07 0.07 0.07 0.00 0.00 0.00 0.76 0.01 0.00 0.00
KIAA19581 0.00 0.00 0.00 0.00 0.00 0.00 0.98 0.00 0.00 0.00
KIAA19582 0.19 0.19 0.19 0.02 0.00 0.02 0.38 0.00 0.00 0.00
To support this claim, we identified the LOH-affected regions of the bladder cancer
from a bulk-sequencing analysis by Li et al. (see Table A.1) and removed all mutations
within these regions from the mutation dataset (6.3% of all variant sites). We then applied
OncoNEM to this reduced data set and compared the solution to the one obtained from the
full data set. Figure A.3 shows that the inferred tree is largely stable and the overall tree
structure remains the same.
3.4.2 Analysis of a case of essential thrombocythemia
In the second case study, we applied OncoNEM to a data set derived by single-cell exome
sequencing of 58 single cells from an essential thrombocythemia [58]. Hou et al. estimated
the average ADO rate to be 0.42 and the FPR to be 6.4× 10−5. Using a census-filtering
threshold of 5, they identified 712 SSNVs. Their final genotype matrix contained 57.7% of
missing values.
The genotypes were binarised, and OncoNEM was applied as in the previous case study.
The inferred tree is shown in Figure 3.11b. Again, the tree suggests that all tumour cells
are descendants of a single founder cell. The majority of cells belong to subpopulations
that are related through a linear trajectory. All detected branching events have occurred late
during tumour development, i.e. after the tumour had already acquired more than 60% of its
mutations.
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These results agree with the somatic mutant allele frequency spectrum analysis of Hou et
al. that suggests that the neoplasm is of monoclonal origin [58], while Kim et al. inferred a
mutation tree with a complex hierarchy [75]. Using BitPhylogeny, Yuan et al. [174] inferred
a polyclonal origin. However, with 58 cells, the data set might be too small for their method
to converge.
OncoNEM estimated the FPR and FNR to be 0.255 and 0.185, respectively (see Figure
3.11 a). The FPR estimate is again higher than expected under the binomial model, whereas
the FNR lies within the expected range. As in the previous case study, running OncoNEM
with similar parameters yields similar trees (see Figure A.4).
Given the error rates inferred by OncoNEM, the log-likelihood of the BitPhylogeny
tree computed under the OncoNEM model is −11584, whereas the OncoNEM tree has a
log-likelihood of −9964. The fact that the OncoNEM solution has a much higher likelihood
than the BitPhylogeny tree shows that the differences are not due to the heuristic nature of
OncoNEM’s search algorithm, but instead suggest that BitPhylogeny did not converge to the
optimal solution.
In summary, these two case studies show how OncoNEM can extend and improve on
previous analyses of this data set.
a b
Fig. 3.11 Results inferred by OncoNEM from essential thrombocythemia dataset. a −
The estimated error rates are α = 0.255 and β = 0.185. b −The inferred tree suggests a
largely linear evolution with some small subpopulations branching off late during tumour
evolution.
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3.5 From cell trees to mutation trees
So far we have focused on the inference of cell or clonal lineage trees. With some small
modifications, the OncoNEM model can be adapted to infer mutation trees. These are trees
that describe the order in which mutations were acquired during tumour evolution. The main
difference between mutation trees and clonal lineage trees is that the nodes of mutation trees
are mutations, whereas the nodes of cell lineage trees are cells. Adapting NEMs to infer
mutation trees yields the likelihood model used by SCITE (single-cell inference of tumour
evolution) [65], which was published shortly after OncoNEM. The option to infer mutation
trees is also implemented in the OncoNEM R package.
Even though the concepts of clonal lineage trees and mutation trees are closely related
and, essentially, both trees can describe the same information, one inference model can be
preferable over the other, depending on the input data. If the number of cells n is larger than
the number of mutations m, inferring mutation trees can be advantageous, as this reduces the
size of the inferred model in comparison to cell lineage trees.
To infer cell lineage trees, we marginalise over the attachment of mutations, whereas
to infer mutation trees, we marginalise over the attachment of cells. For this reason, the
inference model for the mutation tree case is even closer related to traditional NEMs than the
model for cell lineage trees (see Section 3.1.2 for a comparison of the cell lineage tree model
and traditional NEMs).
No inversion of subset relationships As with NEMs, the patterns of upstream nodes
are a superset of the patterns of downstream nodes, or in other words, mutations that occurred
late during tumour evolution are present in a subset of the cells that carry an upstream
mutation.
Targeted perturbations In case of both cell lineage and mutation trees, mutations cor-
respond to perturbations. In case of mutation trees, however, the node of mutation l is the
origin of the perturbation. This is directly analogous to NEMs, where the signalling genes are
the origins of the perturbations. As with NEMs, the effects of the perturbations are observed
via downstream reporters and the connection between graph components and reporters is
unknown a priori.
Graph size and structure As with NEMs, the graph size is defined by the number of
perturbations. There are no unobserved nodes. The only difference in comparison to NEMs
is that the search space is the space of arbitrary trees instead of the space of directed acyclic
graphs.
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Comparison with SCITE
Theoretical comparison
Despite the similarity in the likelihood models, the tools OncoNEM and SCITE [65] show
important differences. Some of these are conceptual while others are technical.
Clonal lineage tree versus mutation tree OncoNEM was primarily developed to infer
clonal lineage trees, whereas the main focus of SCITE is to infer mutation trees. The software
packages of both methods offer options to infer the other type of tree. SCITE, however, does
not infer unobserved nodes, which are needed to account for unobserved subpopulations in
the inference of cell trees.
Inference of error parameters OncoNEM estimates both false positive and false negative
rates. The current implementation of SCITE only infers the false negative rate. Jahn et al.
[65] simply use the FPR estimated directly from the sequencing data. However, as shown
earlier, the FPR estimate from the sequencing data and the false positive rate of the likelihood
model are different conditional probabilities.
Input data OncoNEM uses binary input data, SCITE has two different options (i) a binary
mode and (ii) a mode that distinguishes between heterozygous mutant/normal sites and
homozygous mutant sites.
Inference algorithms OncoNEM uses a heuristic neighbourhood search, whereas SCITE
uses Markov-chain Monte-Carlo sampling (MCMC). A disadvantage of the neighbourhood
search is that for large trees the neighbourhood can become very big and the search becomes
too computationally expensive. The purpose of MCMC is to generate a sample from the
posterior distribution. Thereby MCMC does not generate just one solution tree but a sample
from the distribution of solutions, which allows assessing the uncertainty. In case of On-
coNEM, a list of highest scoring trees can be used to assess stability of the inferred solution.
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Comparison in a simulation study
Salehi et al. [144] compared the performance of OncoNEM and SCITE in a simulation study.
Data simulation Salehi et al. simulated data sets for 10 different tree topologies. In each
case, 10 clones and 48 mutation sites were simulated. Their simulation procedure consists of
three steps.
First, they simulate genotypes for a given tree using a Generalised Dollo Model. Under
this model, a point mutation can only be gained once during the evolution of a tumour, but it
can also be lost again once or several times on independent branches. This is to take into
account the effects of deletions. Second, they simulate the single-cell data. To sample the
number of cells corresponding to each clone, they sample from a Dirichlet-multinomial
distribution
(n1, . . . ,nM)∼ Dirichlet-multinomial(λΦ),
where Φ is a vector containing the ground truth cellular prevalences of the clones and λ is a
distortion parameter. The higher λ , the closer the simulated cellular prevalences are to the
ground truth prevalences. Datasets containing between 50 and 1000 cells were simulated.
However, OncoNEMs performance for data sets with 200 cells or more could not be assessed
because of computational constraints. Third, they introduce ADO errors and doublets. Apart
from errors caused by doublets, no false positives are simulated.
In total Salehi generate data for three scenarios (i) perfect data without ADO and doublets
(denoted as λ = ∞), (ii) data with moderate levels of sampling distortion (λ = 10) in
combination with an ADO rate of 30% as well as 30% doublet cells and (iii) data with a
high level of sampling distortion (λ = 1.12), which is reflective of real data according to the
authors of the study, and again 30% of ADO and doublet cells.
Analysis The data was analysed using OncoNEM, SCITE and ddClone, the method devel-
oped by the authors of this study. As described in Chapter 2, ddClone uses bulk-sequencing
data in addition to the single-cell data for the inference. As in our own simulation studies,
the V-measure was used to evaluate the clustering performance. In addition, the accuracy of
cellular prevalence estimates was evaluated. The accuracy of the inferred tree topology was
not assessed.
Results The results of the simulation study are summarised in Table 3.2. Unsurprisingly,
ddClone outperforms OncoNEM and SCITE in terms of cellular prevalence estimation error
in case of moderate or high sampling distortion, as it obtains additional information about
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Table 3.2 Average cellular prevalence estimation error (top) and V-measure (bottom) with
standard deviation. Data from Salehi et al. [144]. Simulation parametes: (i) λ = ∞, 0%
ADO, 0% doublets; (ii) λ = 10, 30% ADO, 30% doublets; (ii) λ = 1.12, 30% ADO, 30%
doublets;
eΦ (i) (ii) (iii)
OncoNEM 0.04±0.01 0.13±0.03 0.17±0.03
SCITE 0.06±0.01 0.18±0.05 0.18±0.05
ddClone 0.06±0.01 0.07±0.02 0.09±0.03
V-measure (i) (ii) (iii)
OncoNEM 0.90±0.03 0.81±0.03 0.74±0.06
SCITE 0.87±0.09 0.75±0.05 0.71±0.08
ddClone 0.86±0.04 0.79±0.09 0.77±0.06
cellular prevalences from the bulk-sequencing data. OncoNEM and SCITE show a very
similar performance in all cases. In terms of V-measure ddClone does not show a significant
performance advantage in comparison to OncoNEM. OncoNEM and SCITE also show a
similar performance, with OncoNEM performing marginally better on average.
3.6 Limitations
OncoNEM has limitations, some of which were mentioned in a research highlight article by
Davis and Navin [24].
Limitations of model assumptions
The OncoNEM likelihood model is based on the infinite sites assumption, i.e. it assumes
that during tumour evolution every mutation site is only mutated once. Deletions can violate
this assumption as they can lead to the loss of somatic SNVs. If a deletion only affects a
single SNV and occurred in a clone that arose late during tumour evolution, the deletion
affects few of the entries in the genotype matrix. OncoNEM would account for the resulting
discrepancies between observed and expected genotype matrix by assuming additional false
positives or negatives. As the number of additional errors needed to explain the observed data
is small, the likelihood scores will differ only marginally from the scores in the case without
deletion. Therefore, the deletion should not have a significant influence on the inference
result.
However, copy number changes can occur early during tumour evolution. Likewise, they
often affect larger regions of the genome. This means deletions can lead to systematically
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missing mutations. In principle, OncoNEM, which does not account for deletions, could
still explain the observed data by assuming genotyping errors. In these cases, however, the
assumption that observed genotypes are independent and identically distributed is violated.
For these reasons, our general recommendation is to blacklist LOH-affected regions
before OncoNEM inference if copy-number informative data is available. If the evolution of
a tumour is known to be copy number driven and LOH affects large parts of the genome, we
recommend using a copy number based method for inferring tumour evolution.
Similar to deletions, sequencing of doublets can also yield mutation patterns that are
systematically incompatible with a tree structure under the infinite sites assumption. To
account for this, one could extend the OncoNEM search space from directed trees to directed
acyclic graphs. However, this would make the search even more computationally expensive
due to an even larger search space. In addition, it is unclear how robustly OncoNEM would
be able to distinguish whether incompatible mutation patterns are caused by sequencing
errors or doublets. Nevertheless, the simulations performed by Salehi et al. [144] demonstrate
that OncoNEM in its current form can yield good clustering solutions even in the presence of
doublets.
Limitations of global error parameters
OncoNEM uses error parameters that are constant across all sites and cells. Ideally, the
OncoNEM error probabilities would depend on the confidence of the mutation call in a
cell- and site-specific manner. While this is easy to implement, an approach to estimate
these error rates is lacking. One possibility could be to estimate local error parameters by
adjusting global parameters on the basis of local sequencing parameters such as quality
scores. Our simulation studies showed, however, that OncoNEM is robust to changes in
the error parameters. This suggests that local adjustments of these parameters may not be
necessary to obtain robust results and it would be interesting to test this in future simulations.
Restrictions on data set size
OncoNEM’s search algorithms are suitable for handling single-cell datasets of the current
size. In the future data sets are likely to contain many more cells and the inference of cell
trees with the current algorithms will become too computationally expensive.
One of the limiting factors is the heuristic neighbourhood search. As the number of
nodes in the tree grows, the number of trees in the neighbourhood that are scored in each
step becomes larger and larger. To make the search algorithm more efficient, one could
optimise the heuristic search algorithm, for example by limiting the number of neighbouring
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trees generated in each step. In addition, the parameter estimation could be accelerated by
implementing a local parameter optimisation instead of a brute force grid search.
Even with these adaptions, OncoNEM will not be able to infer cell trees for data sets with
a very large number of cells. In this case, we recommend inferring mutation trees instead of
cell trees, which means that the computational cost is mainly determined by the number of
mutations instead of the number of cells. Of course, the number of mutations in the data set
may also be too large. In most cases, it should, however, be possible to reduce the number of
mutations to a number that OncoNEM can handle by limiting the data to mutations that are
of special interest, such as non-synonymous mutations or driver mutations.
Dependence on data quality
As with bulk-sequencing inference methods, single-cell methods depend on the quality of
the input data. On the one hand, this concerns the quality of the sequencing itself which in
turn depends on parameters such as allele drop-out and doublet rates. On the other hand, the
collected cells need to be a representative sample of the tumour to yield a sensible solution.
Sampling biases or under-sampling lead to an underestimation of tumour heterogeneity.
Increasing the number of cells can improve all of these issues, but this needs to be balanced
against sequencing costs and computational constraints. More work is needed to estimate the
number of cells that are required to infer reliable phylogenies.

Chapter 4
Inference of multi-sample phylogenies
So far the thesis has focused on the inference of phylogenetic trees from single-cell
sequencing data. This chapter describes the phylogenetic analysis of ten lethal metastatic
breast cancers using multi-sample bulk sequencing data. In the first part, I present a
new allele-specific multi-sample copy number segmentation algorithm that improves the
copy number based phylogenetic inference (Section 4.1). The second part describes the
phylogenetic analysis. First, I give an overview of the data (Section 4.2.1) and describe
the steps of the phylogenetic analysis (Section 4.2.2), which include the application of the
new segmentation algorithm. Then, I present the inferred trees and compare results across
methods and data types (Section 4.2.3). This chapter contains text from Ross et al. [135]
and figures from De Mattos Arruda et al. [25].
4.1 Allele-specific multi-sample segmentation
As explained in Chapter 2, the reliability of sample tree inference from copy number data
depends on the accurate estimation of the number of mutation events that separate the copy
number profiles of different samples. Two methods that aim to do this are MEDICC [151]
and TuMult [81]. Both of these methods use breakpoint based input data, where breakpoints
are defined as genomic locations that show a change in copy number status [81]. Given the
smallest difference between the breakpoint locations of two samples, these methods assume
that the breakpoints were caused by different events. Therefore, breakpoints that are shared
between samples need to be perfectly aligned with each other to produce phylogenies of high
quality.
Current approaches to inferring copy number profiles The main two steps of in-
ferring allele-specific copy number profiles are (i) the segmentation of chromosomes into
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regions of constant copy number and (ii) the estimation of purity and ploidy values to convert
the segmented relative copy number values into integer copy number profiles. The most fre-
quently used methods to perform the second step are ASCAT (Allele-Specific Copy number
Analysis of Tumors) by Van Loo et al. [164] and ABSOLUTE by Carter et al. [16]. For the
segmentation step, a wide variety of methods exist.
Segmentation algorithms can be distinguished by the mathematical model they use, by
the type of data they segment, total or allele-specific copy number data, and depending on
whether they perform single- or multi-sample segmentation.
• Most segmentation algorithms use circular binary segmentation (CBS) [118], hidden
Markov models (HMM) [44, 98] or regression-based approaches such as piecewise
constant fitting (PCF) [123] and regression trees [18].
• Some methods only segment total copy number data, while others perform allele-
specific segmentation. Allele-specific segmentation can detect copy number neutral
changes, for example when one allele is deleted, and the other one is duplicated.
Allele-specific data is therefore preferable for phylogenetic inference and is used as
input data by MEDICC.
• Some segmentation algorithms can only be applied to a single sample at a time. Multi-
sample segmentation algorithms segment multiple related samples jointly and infer
both private and shared segment boundaries.
Allele-specific versions of some of the methods mentioned above exist. Patchwork [102],
for example, uses CBS and aspcf [114] uses PCF. However, current allele-specific methods
segment each sample on its own and, due to the noise in the data, the inferred locations of
breakpoints that are shared between samples may differ.
To address this problem, the authors of the copy number-based tumour phylogeny infer-
ence algorithm MEDICC performed extensive experimental breakpoint validation of their
data sets [150]. This is an expensive approach which has often been omitted by similar papers.
Mangiola et al. [96] and Gerlinger et al. [50], for example, used size-based heuristic filters
for CNAs instead. However, the fact that a segment is small does not automatically imply
that it is an artefact. Size-based filters do not assess the evidence for a given segment in the
raw segmentation data and therefore cannot distinguish between segments that correspond
to small highly amplified regions and segments that are the result of misaligned segment
boundaries.
While experimental breakpoint validation was not feasible in our study, we wanted to use
a more rigorous approach than a heuristic size filter. We, therefore, addressed the problem of
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multi-sample breakpoint detection by developing asmultipcf (allele-specific multi-sample
piecewise constant fitting), an algorithm performing joint allele-specific segmentation of
multiple samples to infer private and shared segment boundaries of phylogenetically related
samples.
Asmultipcf is based on two copy number segmentation algorithms developed by Nilsen
et al. [114], which use penalised least square principles to fit piecewise constant segments
to the data. The first algorithm, aspcf, performs allele-specific segmentation and is the
segmentation algorithm used in ASCAT Van Loo et al. [164]. The second one, multipcf,
is a multi-sample segmentation algorithm, which is however not allele-specific. Combin-
ing these two algorithms provides a straightforward approach to address the multi-sample
breakpoint inference problem for our phylogenetic analyses. As an extension to the existing
algorithms, asmultipcf handles missing values, making extensive data filtering unnecessary.
The algorithm is described in detail in the following.
4.1.1 Data for allele-specific copy number segmentation
Allele-specific copy number segmentation makes use of two data types log ratios (logR)
and B-allele frequecies (BAF) of germline heterozygous sites. They can be obtained from
sequencing data or SNP (single nucleotide polymorphism) arrays [9].
Log ratio The logR is a relative measure of the total copy number of the cancer cell
population at a given genomic locus. An increase in relation to the baseline logR indicates an
amplification of the genome, whereas a decrease indicates a deletion. LogR values alone can
be used to estimate absolute non-allele-specific copy number profiles. In the following, we
assume that logR values have been adjusted for GC biases before segmentation, for example
using ASCAT’s GCcorrect function.
B-allele frequency The BAF measures the relative abundance of two alternative alleles A
and B at a genomic locus [9],
BAF =
nBi
nAi +n
B
i
. (4.1)
In noise-free data, a homozygous locus has a BAF of 0 or 1, whereas a heterozygous site of
copy number 2 has a BAF of 0.5.
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4.1.2 Copy number segmentation by piecewise constant fitting
In their piecewise constant fitting algorithms, Nilsen et al. [114] use a penalised least squares
approach to evaluate the fit of a segmentation solution to the data. This section describes
the basic principles of their single-sample, multi-sample and allele-specific segmentation
algorithms.
Single sample segmentation (pcf) The simplest case is single-sample non-allele-
specific segmentation. Assume we are given a sequence of logR values y = (y1, . . . ,yp).
Then, the aim is to find a segmentation solution S = {I1, . . . , IM} that minimises the cost
function
L(S|y) =∑
I∈S
∑
j∈I
(y j− yI)2+ γ|S|, (4.2)
where yI is the average of the values y j in segment I and where γ is a penalty parameter that
controls the number of segments |S|.
Multi-sample segmentation (multipcf) In the multi sample case, we have logR mea-
surements yi for each of the samples i = 1, . . . ,n. The aim is to find a single segmentation
that minimises the sum of the costs across all samples
L(S|y1, . . . ,yn) =
n
∑
i=1
L(S|yi). (4.3)
Allele-specific segmentation (aspcf) The allele-specific case, is essentially a multi-
sample segmentation problem. Instead of segmenting logR tracks of different samples, we
are given a logR, and a BAF track y1 and y2 of a single sample and the aim is to segment them
jointly. Before this can be done, some pre-processing steps are necessary. Most importantly
BAFs in y2 are mirrored by replacing y j with 1− y j if y j > 0.5 in order to obtain a single
track in regions of allelic imbalance. Furthermore, we assume that logR and BAF values are
paired, i.e. each BAF has a corresponding logR value. Then the aim is to find a segmentation
that minimises the sum of the costs for the logR and the BAF data
L(S|y1,y2) = L(S|y1)+L(S|y2). (4.4)
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4.1.3 Extension to allele-specific multi-sample segmentation
As noted by Nilsen et al. [114], allele-specific segmentation and multi-sample segmentation
are closely related. Therefore, to perform allele-specific multi-sample segmentation, we use
BAF and logR tracks of all samples in one large multi-sample segmentation.
Asmultipcf largely uses the same pre-processing steps as the allele-specific single sample
algorithm proposed by Nilsen et al. [114]. There is, however, one important difference. The
aspcf algorithm removes sites with missing BAF values before the segmentation. In the
multi-sample setting, this is problematic, as removing sites with incomplete data in just a
single samples could lead to loss of a significant amount of data. To allow for missing values
in the data matrix we extend the penalised least squares approach of Nilsen et al. [114] by
using a weighted least squares function that models missing values in the data matrix.
Given the input data of n samples across p germline variant sites, the pre-processing
yields a single matrix Y= (yi j) ∈ R2n×p that contains both logR and BAF values.
A cost function for weighted segmentation A weight matrix W= (wi j) ∈ R2n×p is
derived by assigning wi j a weight of 0 if yi j is missing and 1 otherwise. Then all missing
values in Y are assigned an arbitrary numeric value. Our aim is to find a segmentation
S = {I1, . . . , IM} that minimizes the least squares cost function
L(S|Y,W,γ) =
2n
∑
i=1
L(S|yi.,wi.,γ) (4.5)
=
2n
∑
i=1
∑
I∈S
∑
j∈I
wi j(yi j− yi,I)2+ γ|S|, (4.6)
where the best fit on a given segment I is the weighted average of the observations on that
segment
yi,I =
∑ j∈I wi jyi j
∑ j∈I wi j
.
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Expanding the square in (4.6) we find
L(S|Y,W,γ) =
2n
∑
i=1
∑
I∈S
∑
j∈I
wi j
(
y2i j−2yi jyi,I + yi,I2
)
+ γ|S| (4.7)
=
2n
∑
i=1
∑
I∈S
∑
j∈I
wi j
(
y2i j−2yi j
∑ j∈I wi jyi j
∑ j∈I wi j
+
(
∑ j∈I wi jyi j
)2(
∑ j∈I wi j
)2
)
+ γ|S| (4.8)
=
2n
∑
i=1
∑
I∈S
(
(∑
j∈I
wi jy2i j)−2
(
∑ j∈I wi jyi j
)2
∑ j∈I wi j
+
(
∑ j∈I wi jyi j
)2
∑ j∈I wi j
)
+ γ|S| (4.9)
=
2n
∑
i=1
∑
I∈S
(
(∑
j∈I
wi jy2i j)−
(
∑ j∈I wi jyi j
)2
∑ j∈I wi j
)
+ γ|S|. (4.10)
To find an optimal segmentation, we can omit the term that is independent of the segmen-
tation and instead minimise the cost function
L′(S|Y,W,γ) =−
2n
∑
i=1
∑
I∈S
(
∑ j∈I wi jyi j
)2
∑ j∈I wi j
+ γ|S|. (4.11)
An exact algorithm for weighted segmentation For a large number of loci p, naive
optimisation is not feasible. Nilsen et al. [114], however, noted that the global segmentation
problem can be broken down into smaller subproblems and used this to develop a dynamic
programming algorithm. The idea behind their algorithm is that, given a breakpoint, the
optimal segmentation solutions on either side of it are independent of each other. In the
following, we adapt their dynamic programming algorithm to our weighted problem.
Algorithm 1: asmultipcf
Input: Matrix Y of log-transformed copy numbers and B allele frequencies (BAF); weight
matrix W; penalty γ > 0;
Output: Segment start indices and matrix of segment averages Y;
Notation: In the following, Ak and Ck denote matrices of size 2n× k that are used to store
the sum in the numerator and denominator of the cost function (Equation 4.11), respectively,
for k different segments I, where column i corresponds to the segment of length k− i+1
ranging from position k− (k− i+1) to k. dk is a vector of length k and stores the first term
of the cost function for the k segments. ek is a vector of length k+1 and stores the overall
cost of different segmentation solutions. Vectors that are obtain by selecting column k of a
matrix M are denoted as m.k.
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1. Initialise Ak and Ck as empty matrices (A0 = [ ], C0 = [ ]). The initial value for the
overall cost is zero (e0 = 0).
2. Iterate for k = 1, . . . , p
• Ak = [Ak−1 0]+w.ky.k
• Ck = [Ck−1 0]+w.k
• dk =−1T
(
Ak ◦Ak ◦C◦−1k
)
where ◦ denotes an element-wise matrix product and
C◦−1k the element-wise inverse
• ek = [ek−1 min(dk + ek−1+ γ)]
storing also the index tk ∈ 1, . . . ,k at which the minimum in the last step is achieved.
3. Find segment start indices from right to left as s1 = tp, s2 = ts1−1, . . . , sM = 1, where
M ≥ 1.
4. Find segment averages
y.m =
(w.smy.sm + · · ·+w.sm−1−1y.sm−1−1)
(w.sm + · · ·+w.sm−1−1)
for m = 1, . . . ,M, where s0 = p+1.
A heuristic algorithm for large data sets Algorithm 1 is of order O(np2), where p is
the number of input loci and n is the number of samples. This means that the segmentation
becomes computationally expensive for long sequences. However, instead of allowing
breakpoints at any of the p positions, Nilsen et al. [114] noted that we can pre-select potential
breakpoints and thereby reduce the runtime to O(nq2) where q is the number of potential
breakpoints. To identify potential breakpoints, different heuristics can be used. Here, we
apply Algorithm 1 to overlapping subsequences, combine all of the inferred breakpoints
and use them as input for the subsequent global segmentation. As in the implementation by
Nilsen et al. [114] we use subsequences of length 5000 with an overlap of 1000. Algorithm
2 describes the fast heuristic version of asmultipcf.
Algorithm 2: Fast asmultipcf
Input: Matrix Y of log-transformed copy numbers and B allele frequencies; Weight matrix
W; penalty γ > 0;
Output: Segment start indices and segment averages
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1. Split data set into overlapping subsequences and apply steps 1 and 2 of Algorithm 1
to each of them in order to find potential breakpoints r0, r1, . . . , rq where r0 = 1 and
rq = p+1.
2. Aggregate sequences between breakpoints by setting xik = ∑
rk−1
j=rk−1 wi jyi j and vik =
∑rk−1j=rk−1 wi j.
3. Calculate segmentation solution by using the aggregated matrices X and V ∈ R2n×q as
input to Algorithm 1 instead of Y and W, respectively.
Post-processing Both algorithms yield a single segmentation solution S for all samples.
However, we expect that only some of the segments will be shared between all samples while
others will be private. While ASCAT can be run directly on the global segmentation solution,
removing unnecessary breakpoints on a per sample base can reduce noise in the segment
average estimates by generating larger segments. To refine breakpoints individually for each
sample, we simply use the breakpoints inferred from the multi-sample segmentation and
rerun steps 2 and 3 of Algorithm 2 on each sample individually based on these potential
breakpoints.
Implementation Asmultipcf is part of the ASCAT R package from version 2.5 on-
wards [163]. The asmultipcf function contains a parameter to select whether the exact
or the fast algorithm should be run, as well as an option to include the per-sample breakpoint
refinement. Furthermore, samples can be weight adjusted to account for quality differences
in the data.
4.1.4 Segmentation case studies
This section compares tree inference results obtained from single- versus multi-sample
segmentation data using two case studies.
Case 298 This case is relatively simple with few copy number changes and only eight
metastasis samples. Using the default values for multi-sample segmentation, asmultipcf
inferred an average of 44 segments per sample. For single-sample segmentation, the penalty
parameter was set to 80 to achieve a similar segmentation resolution (average of 44.1
segments per sample). The subsequent steps including the ASCAT and MEDICC analysis
were performed as described in section 4.2.2. The resulting trees are shown in Figure 4.1.
The branches leading to the leaf nodes are much longer in the single-sample segmentation
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Fig. 4.1 Comparison of MEDICC trees inferred for case 298 using single-sample segmenta-
tion (left) and multi-sample segmentation (right).
tree than the multi-sample segmentation tree. There are two alternative explanations for
the difference in branch lengths: (i) under-segmentation of the multi-sample data, which
could make samples look more similar to each other than they actually are, leading to shorter
branches or (ii) misalignment of segment boundaries in the single-sample data, which forces
MEDICC to infer more copy number changes than there actually are, leading to longer
branches. The fact that the number of segments in the input data for both trees is comparable
suggests that the longer branches are not due to copy number changes that are only detected
by the single-sample segmentation.
In the tree inferred from individually segmented samples, all branches connecting internal
nodes have a similar evolutionary distance. In comparison, the tree inferred from jointly
segmented samples shows a clearer divide between sample 012 and the group of closely
related samples 004, 005, 020, 021, 022. This divide is also inferred by other methods
such as OncoNEM (see Section 4.2.3.2), which shows that multi-sample segmentation may
help to infer a more accurate tree structure. It also suggests that the long leaf branches in
the single-sample segmentation tree are due to reason (ii), misaligned segment boundaries.
However, this cannot be proven definitively without knowledge of the ground truth.
Case 308 The previous case shows that given few samples and a small number of copy
number changes, the overall tree structure may be recovered even with single-sample segmen-
tation, but the inference of finer details of the tree like branch lengths is less reliable. However,
as the number of samples increases the number of misaligned segment boundaries increases,
too. An example for this is case 308, for which 19 samples were available. Multi-sample
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segmentation was run with default parameters. For the single-sample segmentation, the
penalty parameter was set to the maximum of 800 to reduce the number of noisy fragments.
Figure 4.2 shows the segmentation of chromosome 19 for this case. Instead of the
3 breakpoints inferred by multi-sample segmentation, single-sample segmentation of all
samples yields a total of 11 breakpoints. Overall single-sample segmentation infers five
clearly distinct segments, whereas multi-sample segmentation infers four, omitting a separate
segment at the start of chromosome 19. While this could indicate a lower sensitivity of the
multi-sample segmentation, the set of samples for which this segment was inferred does
not match with the tree structure inferred by the other methods (see Figure A.5). This
suggests that the extra segment inferred by single-sample segmentation is an artefact. It
could, however, also be a clonal mutation that was missed in a large number of samples.
Running MEDICC on the single-sample segmentation data failed due to computational
constraints, as a result of the large number of segments. To reduce the size of the dataset, we
removed all segments spanning less than 500 000 bp, as done by Mangiola et al. [96]. This
yields an average of 38.5 segments per sample, while multi-sample segmentation produced
an average of 37 segments per sample. Despite the size filtering, the total number of segments
of the single-sample data was much higher than that of the multi-sample data (104 versus
53). MEDICC inference on a 320GB node took 51.5 hours for the single-sample data versus
less than 2 hours for the multi-sample data.
The resulting trees are shown in Figure 4.3. They differ in the placement of samples (018
and 022), which, according to LICHeE, contain a mix of the two major subpopulations (see
Figure A.5). As with case 298, the evolutionary distances between samples that are inferred
to be closely related by alternative methods are smaller in the multi-sample segmentation tree
than in the single-sample segmentation tree. Furthermore, finer details of the relationship
structures are more similar between the multi-sample segmentation tree and the trees inferred
by alternative methods. For example, in the multi-sample segmentation tree, samples 005
and 014 are placed close to the cluster containing 006, 007, 008, 009 and 010, as inferred by
OncoNEM, Treeomics and LICHeE (see Figure A.5).
4.1.5 Discussion
Our case studies suggest that the independent segmentation of related samples can artificially
inflate estimates of tumour heterogeneity. We developed an algorithm for the joint allele-
specific segmentation of multiple samples, which addresses this problem. A limitation of
multi-sample segmentation is that it can potentially underestimate tumour heterogeneity
because CNAs that are shared by many samples are more likely to be detected than CNAs
that are shared by fewer samples or private. Nevertheless, even though the total number of
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Fig. 4.2 Copy number inference of chromosome 19 for case 308. The blue and magenta
lines show the major and minor integer copy number values inferred with ASCAT by
single-sample segmentation. These lines are plotted with a slight vertical offset to show
both lines in regions of balanced allele frequencies. The vertical green and blue lines indicate
the breakpoints inferred with single-sample and multi-sample segmentation, respectively.
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Fig. 4.3 Comparison of MEDICC trees inferred for case 308 using single-sample segmenta-
tion (left) and multi-sample segmentation (right).
segments inferred by multi-sample segmentation was smaller in our test cases, the resulting
trees were more similar to trees inferred by other methods.
To avoid under-segmentation of the multi-sample method, the penalty parameter γ that
controls the number of inferred segments could be further optimised. As always, there is a
trade-off between sensitivity and specificity. If the segmented data is to be analysed with
downstream tools such as MEDICC, computational constraints of these methods also need to
be taken into account. Multi-sample segmentation can substantially reduce the computation
time of MEDICC.
Overall, our case studies show that allele-specific multi-sample segmentation can improve
the copy number-based phylogenetic analysis of multiple related samples.
4.2 Phylogenetic analysis of metastatic breast cancers
So far, this chapter focused on a new method for multi-sample segmentation. The motivation
for developing this algorithm was a phylogenetic study, which analysed a data set of metastatic
breast cancers using various multi-sample inference algorithms and which is described in the
remainder of this chapter.
4.2.1 Data
Samples The following study contains samples from ten breast cancer patients who died
with metastatic disease that had become resistant to multiple lines of therapy. The samples
analysed comprise metastatic samples of each patient (average: 10.6 per patient, range: 3 to
4.2 Phylogenetic analysis of metastatic breast cancers 77
19), which were collected during autopsies, as well as primary tumour samples from surgery
for six out of the ten patients. For some of the patients, cell-free DNA from plasma samples
and other body fluids that had been collected at varying time points was also available
(average: 4.7 per patient, range: 1 to 9). For all patients, blood samples were used as matched
normal.
Sequencing Shallow whole genome sequencing (sWGS) data was available for the primary
tumour samples, the metastasis samples and most of the fluid samples. Furthermore, a subset
of metastases (average: 7.6 per patient, range: 1 to 19) had been analysed using whole exome
sequencing (WES). All samples had been subjected to deep targeted sequencing (TS) using
a total of 499 amplicons, which had been designed based on somatic mutations discovered
in the WES data (mean 49.9 amplicons/patient, range 13-189 amplicons, mean sequencing
depth of 7570 to 29891x). Since not all data types are available for all samples, the samples
used for tree inference vary depending on the input required by each method.
Variant calling Data pre-processing was performed by Oscar Rueda and Stephen-John
Sammut (Cancer Research Cambridge Institute). In particular, germline SNVs were called
from WES data of matched blood samples. Somatic SNVs were called from WES data of
all other samples and were rigorously filtered to exclude germline variants and other false
positives.
4.2.2 Methods
In the following, we describe the phylogenetic analysis using a set of five different phyloge-
netic methods (see Chapter 2 for a more detailed description of the methods).
Method selection We decided to use three sample tree methods, MEDICC, Treeomics and
OncoNEM, and two deconvolution methods, PyClone in combination with LICHeE as well as
SuperFreq. MEDICC is the only method that performs a comprehensive phylogenetic analysis
of copy number profiles. Treeomics is a point mutation based method that has specifically
been developed for the analysis of metastases and performs limited subclone detection. While
OncoNEM has been developed for the analysis of point mutations from single cells, it can
also be applied to multi-sample data, assuming that mixing of subpopulations is limited. In
contrast to Treeomics, it does not detect subpopulations but can be applied to large datasets.
PyClone is a standard method for clustering mutation frequencies but does not reconstruct
phylogenies. Therefore, we use LICHeE to infer trees from the PyClone clusters. SuperFreq
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Table 4.1 Overview of phylogenetic methods used for the analysis of metastatic breast
cancers including the sequencing data that was used to infer the tree, the type of variants
used as phylogenetic markers, the input data required, the type of tree inferred and whether
the method performs clonal deconvolution.
Method Data Variants Input Tree type Clonal de-
convolution
MEDICC sWGS + WES CNA Allele-specific copy number profiles sample tree no
OncoNEM WES / TSeq SNV Binary mutation profiles sample tree no
Treeomics WES / TSeq SNV Total read depth + read depth of
variant allele at every SNV location
across all samples
sample tree limited
SuperFreq WES SNV and CNA Aligned reads (bam files) + prelimi-
nary variant calls (vcf files)
clone tree yes
PyClone + LICHeE WES / TSeq + sWGS SNV Variant allele frequencies, copy
number profiles + purity estimates
clone tree yes
is one of the few methods that use both point mutations and copy number changes as
phylogenetic markers. It performs clustering and tree inference.
All methods were applied to the WES data, while OncoNEM, Treeomics and Py-
Clone/LICHeE were also applied to the TS data. An overview of the methods used is
shown in table 4.1.
MEDICC A combination of shallow whole-genome sequencing and exome sequencing
data was used to infer the allele-specific copy number profiles used for the MEDICC analysis.
The reason for this is that the higher coverage of WES data is needed to estimate BAFs, while
sWGS is expected to provide better estimates of logRs than the exome sequencing data due
to smaller biases in the sequencing depth.
The use of sWGS and WES is not ideal, as they both provide data of limited resolution.
The read counts of sWGS data need to be binned to estimate log ratios, while the BAFs can
only be estimated for a small part of the genome. For this reason, the inferred allele-specific
copy number profiles are expected to be of relatively low resolution. LogR values were
estimated from sWGS using QDNAseq 1.2.4 [147, 146] by Oscar Rueda (Cancer Research
UK Cambridge Institute). The QDNAseq estimates are based on bins of size 100kb. In
addition to estimating binned logR values, QDNAseq was also used to adjust estimates for
sequence mappability and GC content of the DNA to account for biases in the read depth.
BAFs were calculated from WES data at sites of previously inferred germline SNVs using
alleleCount 3.1.1 [15].
To make logR and BAF data compatible for segmentation, each BAF was assigned a
binned logR based on the location of the corresponding germline SNV using a custom R
script. Log ratios and B-allele frequencies were segmented on a per case basis using the allele-
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specific multi-sample segmentation algorithm described in Section 4.1 with default penalty
parameter. Using the segmented BAF and logR values, allele-specific copy number profiles
were inferred with ASCAT 2.5 [163]. The raw ASCAT copy number profiles were visually
compared across samples for each case, and ASCAT was rerun with manually adjusted
ploidy and purity estimates where necessary, to obtain the final discrete copy number profiles.
The reason for this is that diploid and tetraploid solutions often fit almost equally well and
copy number callers like ASCAT and ABSOLUTE struggle to infer the true underlying
ploidy. An example of this is shown in Figure 4.4. To date, this is an unsolved problem
in the inference of copy numbers and to obtain high-quality copy number profiles manual
curation is needed. We selected a single baseline ploidy, diploid or tetraploid, for each
case by comparing samples within a case and while aiming to achieve a fit where the raw,
unrounded copy number values lie close to integer values.
MEDICC assumes that a region that has been affected by a homozygous deletion cannot
show an increase in copy number later in the phylogeny. This makes sense from a biological
perspective. However, given that MEDICC does not account for noise in the data, spurious
homozygous deletions can have a big impact on the inferred phylogeny. For this reason,
regions that show a homozygous deletion in any sample were removed from all samples of
that case. Furthermore, regions with constant integer copy number values across all samples
were compressed to single integer values to reduce the size of the input data. To comply with
MEDICC requirements, a maximum copy number cut-off of nine was applied to both major
and minor copy number profiles, replacing any values exceeding this threshold. Finally,
MEDICC (devel branch, commit da7ed4a) [149] with ancestor reconstruction switched on
was used to infer the phylogenies. Trees were plotted using a custom R script.
Treeomics Treeomics was used to infer phylogenies from both WES and targeted se-
quencing data. For each case, Treeomics was used to calculate the posterior probabilities
of a variant being present based on total read depth and the number of reads covering the
alternative allele. All sites where the posterior probabilities were lower than 0.5 in all samples
were removed, as these are likely to be false positives.
Treeomics offers a variety of inference options. In particular, it has an option to test for
subclones as part of the tree inference as well as different options that allow reducing the
memory requirements for the inference. A disadvantage of the low memory options is that
the detection of the optimal solution is no longer guaranteed and it is not recommended to
use this in combination with subclone detection (Johannes Reiter, personal communication).
For our analysis, subclone detection was a priority. Therefore, we decided to reduce the
number of samples for some of the cases, to make the Treeomics analysis with subclone
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Fig. 4.4 Copy number estimation for sample 004 of case 298. a − ASCAT sunrise plot.
This plot shows the goodness of fit for varying ploidy and purity parameters. The green
cross marks the parameters estimated by ASCAT, the red cross marks the manually selected
parameter values. The corresponding raw copy number profiles are shown in panels b and c,
respectively. b − Despite the high goodness of fit for the ploidy parameter of 2.2 estimated
by ASCAT, the raw copy number values of chromosome 1, 9 as well as large regions of
chromosome 8 are far away from integer values. c − Given a ploidy parameter of 4.2, the
raw values of most regions of the genome are close to integer values. For 4 out of the
8 samples of case 298, ASCAT automatically estimated a ploidy of around 4 (data not
shown).
detection computationally feasible on a 320GB cluster node. To keep the mutation profiles as
diverse as possible and to maintain a good representation of the different tumour populations,
samples that had a mutation profile similar to one of the remaining samples were excluded
preferentially. Finally, Treeomics 1.7.3 [131] was applied to each case with subclone
detection switched on and all other parameters set to default. Trees were plotted using a
custom R script.
OncoNEM Like Treeomics, OncoNEM was used to infer phylogenies from both WES and
targeted sequencing data. Binary mutation profiles were obtained from the filtered Treeomics
posterior probability matrices by setting all entries with a mutation probability smaller than
0.5 to 0 and to 1 otherwise. Alternatively, standard variant callers could have been used to
infer binary mutation profiles. However, using the output from Treeomics helps ensure that
differences in the results between the OncoNEM and Treeomics are due to methodological
reasons instead of differences in the input data. The OncoNEM analysis was performed using
error parameter optimisation over a parameter range from 0.0001 to 0.1. The Bayes factor
threshold epsilon was set to 2 in order to avoid overly strict clustering.
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SuperFreq SuperFreq was used to infer clone trees and the corresponding sample com-
positions from WES data. As input, SuperFreq requires preliminary liberal variant calls
which are then filtered as part of the SuperFreq pipeline. Pileup files of the WES data were
generated using samtools 1.3.1 mpileup [49] using a maximum depth threshold of 10000,
a minimum mapping quality of 1 and a minimum base quality of 15. Variant calling was
performed using VarScan 2.4.3 mpileup2cns [78] with a p-value filter of 0.01, no strand-bias
filter and the variant flag set to only obtain variant sites as recommended in the SuperFreq
manual. Finally, SuperFreq 0.9.17 [40] was run with default parameters using the normal of
all cases apart from DET52 as reference normals for each case. SuperFreq does not generate
figures or data files of the inferred tree structure, but only visualises the subset relationships
and sample compositions in a fish plot. Tree structures were therefore extracted manually
and plotted using custom scripts.
PyClone and LICHeE PyClone and LICHeE were used to infer clone trees and the
corresponding sample compositions from both WES and targeted sequencing data.
LICHeE offers different options for the tree inference. Either it can infer trees directly
from VAFs of SNVs, in which case it performs clustering of VAFs before inferring the
clone tree, or it can be applied to previously inferred mutation clusters in which case it only
performs the tree inference step. We decided to use the second option because, in contrast to
other deconvolution methods, LICHeE does not offer the possibility to adjust variant allele
frequencies for copy number aberration related biases.
Therefore, the first step of the analysis was to infer mutation clusters and their cellular
prevalences for each sample using PyClone 0.13.0 [138]. PyClone was run using a beta-
binomial density. A minimum cluster size of 3 was selected for WES data, while no minimum
cluster size was set for TS data, due to the smaller number of mutations. The input parental
copy number and tumour content (purity) estimates were inferred with ASCAT 2.4 using
allele-specific single-sample segmentation and default parameters. The start and end points
of copy number segments are defined by the location of heterozygous germline sites. Variants
that fall between segments have an unknown copy number status and were excluded from the
analysis. PyClone was run for 40000 iterations using a burn-in sample of 20000. This analysis
was performed by Stephen-John Sammut (Cancer Research UK Cambridge Institute).
To remove spurious clusters from the PyClone output, two filtering steps were performed.
First, low prevalence clusters that did not exceed a cellular prevalence of 0.1 in the WES
data in any of the samples were removed, as they tend to attract noisy mutations of low
frequency. This step was skipped for the targeted sequencing data, where VAF estimates
are more precise. Second, if multiple clusters were present in all samples, all but the cluster
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Fig. 4.5 Example of PyClone and LICHeE results for case 298. Top – PyClone clustering
result. There are two clusters which are present in all samples, cluster 1 and cluster 4.
The sum of the cellular prevalences of these two clusters exceeds 1 for most samples
and the cellular prevalence of cluster 1 is smaller than the cellular prevalence of cluster 4.
According to the sum-rule (see Chapter 2) this means that these two clusters describe a
linear phylogeny where the subpopulation carrying the mutations of cluster 1 is a descendant
of the subpopulation carrying the mutations of cluster 4. The same applies to the clusters
4 and 6. However, according to the crossing rule (see Chapter 2), cluster 1 and cluster 6
describe a branching phylogeny, because the cellular prevalence of cluster 1 is sometimes
smaller and sometimes larger than the cellular prevalence of cluster 6. At the same time,
the sum of the cellular prevalences of cluster 1 and 6 is higher than the cellular prevalence
of cluster 4. This shows that the three clusters 1, 4 and 6 are not compatible. For this
reason, cluster 1 was excluded from the analysis. Clusters 4 and 5 are also incompatible:
Sample 020 suggests that they form a linear phylogeny because the sum of the cellular
prevalence is larger than 1, but in sample 021 the cellular prevalence estimate of cluster
5 is higher than that of cluster 4. However, the error bars indicate a large uncertainty
in the cellular prevalence estimates. LICHeE takes cellular prevalence errors into account
through a global parameter that needs to be specified by the user. Bottom – Given a
cellular prevalence estimate error of 0.3, LICHeE infers a phylogeny where a subpopulation
carrying cluster 4 occurred first. It gave rise to a subpopulation carrying cluster 6 which in
turn gave rise to a subpopulation carrying cluster 5. Furthermore, samples 012 shows a
private mutation cluster (3) and samples 006 and 007 belong to a subpopulation defined
by cluster 2, which branched off from the clonal cluster 4.
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with the highest cellular prevalence were removed. In many cases, these ubiquitous medium
prevalence clusters are incompatible with most of the other clusters, which suggests that
they are spurious clusters (see Figure 4.5). A possible explanation for these clusters are
errors in the copy number based adjustment of variant allele frequencies. While LICHeE can
handle incompatible clusters by using a user-specified error range for the cellular prevalence
estimates, keeping too many incompatible clusters in the input data yields a solution that
ignores a large portion of the inferred clusters.
In addition to cellular prevalences for each mutation cluster and sample, LICHeE requires
a binary profile for each cluster that indicates if the cluster is classified as present in a given
sample. We decided to infer these binary profiles based on the VAFs of the mutation set
rather than the cellular prevalences, as the copy number adjustment needed to obtain cellular
prevalences is likely to add noise to the data. In particular, the cellular prevalence estimates
of low-frequency clusters are expected to be less accurate than those of high-frequency
clusters, because the copy number profiles used for the adjustment are dominated by the
major population in the sample.
For the WES data, a mutation was classified as present in a given sample if its VAF was
larger than 0.01. For the TS data, we used the VAFs of 8 control samples that had been
sequenced for each case to select the variant calling threshold in a site-specific manner. More
precisely, a mutation was called present in a sample if its VAF was at least three standard
deviations higher than the mean VAF of the control samples at the corresponding site. For
both WES and TS data, a mutation cluster was called present if at least 40% of its mutation
were called present in a sample.
Finally, LICHeE (commit 238770c) [125] was used to infer clone trees and sample
compositions, assuming a cellular prevalence estimate error of 0.3.
4.2.3 Results
In this section, we discuss the tree inference results. Comparing the trees inferred by the
different methods in a quantitative manner is challenging for several reasons.
Trees vary in their structure. Some methods infer sample trees, whereas others infer
clone trees and the corresponding sample compositions. In case of clone trees and assuming
that mixing of subpopulations is detected, the resulting graph is not a tree, but a directed
acyclic graph, where nodes that correspond to samples can have multiple parents.
Building blocks vary between trees. The sample composition of each tree depends
on various factors. First, the required data type needs to be available for a given method.
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Second, the data of a sample has to be of sufficient quality to be analysed, which can also be
method specific. Third, some methods have computational constraints regarding the number
of samples they can analyse, requiring the exclusion of samples.
Evolutionary markers vary between trees. MEDICC uses copy number changes,
whereas SuperFreq uses a combination of CNAs and SNVs. Treeomics, OncoNEM and
LICHeE analyse only SNVs. Even if methods analyse the same type of variants, the com-
position of the variants analysed can vary. For MEDICC we used copy number profiles
inferred with ASCAT from sWGS and WES data, whereas SuperFreq uses its own pipeline
to call copy number aberrations purely from WES data, yielding different sets of CNAs.
Furthermore, SuperFreq filters out most of the SNVs that are in regions affected by copy
number changes and also removes mutations that are only detected in a single sample. For
this reason, the SuperFreq inference is based only on a fraction of the SNVs used by other
SNV-based methods. Similarly, many SNVs are removed during the PyClone and LICHeE
analysis.
For these reasons, robust quantitative comparison of the different methods is challenging.
In the following, we restrict ourselves to a mainly qualitative comparison. We start by
evaluating distances between trees to assess the similarity of trees inferred by different
methods across cases. Then we discuss two of the ten cases in detail and finally summarise
the main observed advantages and disadvantages of the different methods.
4.2.3.1 Comparison of tree similarities across cases
To assess the similarity of the inferred trees across all cases, we calculated pairwise distances
between the WES trees of all methods. To make the results of different methods comparable,
we converted the directed acyclic graphs inferred by LICHeE and SuperFreq into trees
by assigning each sample containing a mix of subpopulations to the branch of its major
subpopulation. We then removed samples that were not analysed by all methods from the
tree and normalised the total branch length of the tree to one. Next, we calculated the
pairwise-sample shortest path distance for each pair of methods and each case as described
in Chapter 3. To account for the fact that the number of samples varies across cases, we
normalised the distances by the number of sample pairs. Finally, we averaged the distances
across cases. The resulting distance matrix is shown in Figure 4.6.
Trees inferred by the sample tree methods Treeomics, OncoNEM and MEDICC are more
similar to each other than to the results of deconvolution methods. This is not surprising
because the deconvolution methods often group several samples into a single subpopulation,
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which yields a pairwise-sample distance of zero, while the sample tree methods assign
most samples to separate branches. More surprisingly, the agreement between the two
deconvolution methods SuperFreq and LICHeE is even lower than between either of them
and the sample tree methods.
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Fig. 4.6 Heatmap of normalised pairwise-sample shortest path distances averaged across
all cases.
4.2.3.2 Case 298
Trees inferred from WES and sWGS data are shown in Figure 4.7, whereas trees inferred
from TS data are shown in Figure 4.9. In the figures for MEDICC, OncoNEM and Treeomics,
distances in the direction of the y-axis correspond to the evolutionary distance or the number
of accumulated mutations. In the figures for SuperFreq and LICHeE, the numbers in the
nodes of the trees correspond to the number of mutations in the clusters. Samples in these
figures are coloured to reflect the subpopulations they contain. The size of the coloured areas
roughly corresponds to the cellular prevalence estimates of the subpopulations.
Tree structure Based on WES and sWGS data, all methods infer a clear branching
evolution, with the meninges metastases (006, 007) on one main branch and the lymph node
(004, 005), liver (020, 021, 022) and lung (012) metastases on the other main branch (see
Figure 4.7). Within the second main branch, OncoNEM, Treeomics, MEDICC and LICHeE
infer an early divergence that gave rise to the lung metastasis, whereas SuperFreq does not
identify any private mutations for sample 012. The inferred relationships between the lymph
node and liver metastases differ between methods. OncoNEM, Treeomics and MEDICC
86 Inference of multi-sample phylogenies
all infer different albeit close relationships, whereas LICHeE concludes that they all belong
to the same subpopulation. SuperFreq infers that 004, 005, 020, 021 belong to a single
subpopulation whereas 022 belongs to a descendant of that subpopulation.
The TS based inference confirms these results (see Figure 4.9). However, using this data,
LICHeE cannot identify mutations private to 012 due to variant filtering (see Figure 4.10).
OncoNEM and Treeomics, yield identical results and infer that 020 and 021 belong to an
ancestral population of 004, 005 and 022. The WES based tree that agrees best with this
result is the one inferred by Treeomics.
Mixing of subpopulation Out of the tested methods LICHeE, SuperFreq and Treeomics
are the only ones designed to detect mixing of subpopulations within samples. SuperFreq
infers that a small fraction of the cells in sample 012 belong to the same subpopulation as
samples 006 and 007. While LICHeE does not detect mixing in the WES data, its TS data
findings support the SuperFreq result. Treeomics does not detect mixed subpopulations in
either of the datasets.
Two different scenarios can explain the mixing of subpopulations in 012. First, it could
be due to cross-seeding between metastases. Alternatively, 012 may have been seeded by
an ancestral stem population, which evolved into two independent subpopulations within
the metastasis and then gave rise to the other metastases. As the time at which the different
metastases occurred is unknown, none of the two possibilities can be selected with certainty.
Both SuperFreq and LICHeE infer that multiple samples contain cells from the stem pop-
ulation. However, as described in the methods section, the inference of cellular prevalences
can be unreliable. This is also indicated by the fact that cellular prevalence estimates vary
strongly between data types. For samples 006 and 007, for example, LICHeE infers a cellular
prevalence of the stem population of 0.44 and 0.5 based on the WES data versus 0 and 0.05
based on the TS data.
Mutation assignment To assess the branch length estimation, we measured the branch
lengths of the core tree, i.e. branches connecting the root of the tree with the most recent
common ancestor of each of the three main subpopulations. We then calculated pairwise
Pearson correlation coefficients between those branch lengths of all WES based trees (see
Figure 4.11). The highest correlation was found between the OncoNEM and Treeomics
estimates (0.98). This is expected because these methods are the most similar ones. Even
though MEDICC analyses copy number changes, the branch length estimates showed a
high correlation with OncoNEM and Treeomics (0.85 and 0.87). SuperFreq’s branch length
estimates were weakly correlated with those of OncoNEM (0.46), Treeomics (0.40) and
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MEDICC (0.44), whereas LICHeE showed a negative correlation in relation to most of the
methods.
Next, we evaluated how many point mutations of the WES data passed the analysis
pipelines. Treeomics did not filter out any of the mutations, while OncoNEM’s edge assign-
ment was ambiguous for 2.3% of the mutations. PyClone/LICHeE and SuperFreq analysis
removed 33.6% and 72.5% of mutations, respectively.
Furthermore, we tested if methods group the same mutations into clusters. A visual
comparison of mutation clusters is shown in Figures 4.8 (WES) and 4.10 (TS). Considering
only those mutations that are assigned by all methods (31 out of 131), the methods achieve
perfect agreement in the WES case. In the TS case, LICHeE differs from Treeomics and
OncoNEM in the assignment of 2 out of 16 mutations. Overall, Treeomics and OncoNEM
infer very similar mutation clusters, achieving a V-measure cluster similarity score of 0.91
for WES data, even though they assign almost all mutations. LICHeE performs well at
assigning mutations that are present in many of the samples. However, it misclassifies a
large fraction of the mutations that are present in a single sample. For example, using the
WES data, it clusters all the private mutations of samples 004, 005, 012, 020, 021 and 022
together and assigns them to a single mutation cluster that is private to sample 012. Similarly,
it does not distinguish between the private mutations of sample 006 and 007 and clusters
them together with the mutations shared by both samples. For this reason, its V-measure in
relation to Treeomics and OncoNEM is relatively low (0.77 and 0.78 respectively for WES
data). SuperFreq only assigns the mutations most methods agree on, which suggests that it
restricts itself to high confidence assignments.
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4.2.3.3 Case 290
Tree structure Overall, the phylogenetic analysis of 290 reveals three main subpopula-
tions (Figure 4.12). Population A is represented by a single sample (024) from a stomach
metastasis and was identified by all methods but SuperFreq. Population B comprises the brain
metastases (005, 007, 008) as well as a subset of the liver metastases (018, 019). Population
C includes the remaining liver metastases (015, 016-A, 016-B, 021).
The sample tree methods differ in their assignments of two liver metastases, 014 and
017. Treeomics, OncoNEM and MEDICC either assign them to population B or C. The
uncertainty in placing these samples is not surprising, given that LICHeE infers that both
contain a mix of cells from B and C. SuperFreq finds mixing of independent populations
only in sample 014.
While the methods mostly agree on the assignment of samples to subpopulations, the
tree structure connecting them is less clear. From the WES data, OncoNEM, Treeomics and
MEDICC infer that population A branches off from an early ancestral population of B and
C. LICHeE infers that all three developed from one shared most recent common ancestor.
SuperFreq fails to identify a stem subpopulation. However, it infers one mutation cluster that
is present in all samples (blue node in Figure 4.12). Most of the mutations in this cluster are
classified as clonal by the other methods. This is shown in Figure 4.13 where the ubiquitous
SuperFreq cluster is marked in yellow, and the clonal mutations of the other methods are
marked in black. This finding suggests that the ubiquitous mutation cluster does not belong
to an independent population but defines the common ancestor of the other two branches
inferred by SuperFreq. Based on the TS data, in contrast, Treeomics and OncoNEM infer that
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population B branched off from an early ancestral population of A and C, whereas LICHeE
infers only two diverging branches, B and C.
Subpopulations Overall, mixed subpopulations were detected much more frequently
than in the previous case. Out of the 14 samples, a mix of the two main subpopulations B
and C was detected in eight samples by at least one method and in four using at least two
different methods or data types (see Table 4.2). LICHeE inferred more mixing than any other
method and identified more events in the TS than in the WES data. Treeomics was unable to
detect any mixing of subpopulations in the WES but detected some mixing in the TS data.
SuperFreq could only be applied to WES data and identified mixing in a single sample.
Given that the ground truth is unknown, it is impossible to decide whether LICHeE
detects more mixing events than the other methods because it is more sensitive or because it
infers more false positives. Its sensitivity can, however, be adapted by changing the filtering
thresholds for the PyClone output. Out of the four mixing events that were identified using
different methods or data types and which are therefore less likely to be artefacts, LICHeE
identifies 100% of the tested cases from TS data and 75% from WES data. Treeomics
identifies 75% from TS and 0% from WES data and SuperFreq detects 25% from WES
data. The fact that Treeomics did not identify mixing in the WES data while all of the other
methods detected at least one event suggests that it has low sensitivity on this type of data.
Even though OncoNEM cannot identify mixing of subpopulations, the mutation matrices
support some of the mixing events, as they reveal repeatedly occurring mutation patterns that
are incompatible with a tree structure. The WES mutation matrix supports three of the four
high confidence mixing events (Figure 4.13), while the TS analysis supports two (Figure
4.15). Regions of incompatible mutations that agree with the mixing events detected by other
methods are marked with white horizontal bars in these figures.
All in all, it seems likely that there are multiple metastases with a combination of the
subpopulations B and C. Given that there are multiple mixed samples, this has to be at least
partially due to multi-seeding or cross-seeding events.
Mutation assignment As in the previous case, we evaluated the correlation of branch
lengths in the stable core tree between different methods (see Figure 4.16). For this analysis,
the ubiquitous SuperFreq cluster was interpreted as a clonal cluster. Again, the branch lengths
of the core tree estimated by OncoNEM and Treeomics show a strong correlation (0.97).
The correlation of MEDICC with OncoNEM and Treeomics is 0.85 and 0.89, respectively.
Unlike in the previous case, OncoNEM and Treeomics also show a good correlation with
LICHeE (0.83 and 0.76) and SuperFreq (0.81 and 0.66).
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However, many of the variants get lost during the PyClone and LICHeE inference pipeline.
Out of the initial 499 variants identified by WES, the 12 clusters inferred by PyClone contain
336. Only 8 clusters pass the quality filtering that removes spurious clusters, reducing the
number of variants to 219. Out of the remaining 8 clusters, LICHeE ignores 3. The final
tree, therefore, contains only 192 mutations, which corresponds to 38% of initial mutations.
In case of SuperFreq, 17% of point mutations passed variant filtering, whereas OncoNEM
assigns 93% of mutations to a cluster. Treeomics uses all of the mutations provided. The
unassigned mutations in Figure 4.13 are due to the smaller number of samples analysed by
Treeomics.
As before, we tested if methods assign mutations to equivalent branches in the trees they
infer (see Figures 4.13 and 4.15). In this case, methods do not entirely agree on the clustering
of the mutations assigned by all methods. Figure 4.16 shows the pairwise V-measure cluster
similarity scores, which were calculated based on mutations assigned by all methods only.
The V-measure is highest between SuperFreq and LICHeE as well as OncoNEM and LICHeE
but is again impacted by the large fraction of unassigned mutations. Taking into account the
other mutations as well, PyClone again clusters low-frequency mutations together even if
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Table 4.2 Inference of subpopulations by different methods for case 290. Shown are all
samples for which at least one method inferred mixing of subpopulations B and C in at least
one data type. A tick mark indicates that mixing was detected, whereas a cross symbolises
the opposite. Samples that had to be excluded from an analysis are marked with NA. Note
that Treeomics identifies mixing of subpopulations within population C in some samples.
These events are not included in this table.
Method Data 014 015 016-A 016-B-WT 016-B-muc 016-B-IDC 017 018
P. + LICHeE WES ✓ × ✓ ✓ × ✓ × ×
TS ✓ ✓ ✓ NA ✓ ✓ ✓ ×
Treeomics WES × × × NA NA NA × ×
TS ✓ × × NA × ✓ ✓ ✓
SuperFreq WES ✓ × × × × × × ×
they occur in different samples (turquoise cluster in Figure 4.13 and pink cluster in 4.15),
whereas SuperFreq excludes most of them.
In addition to the clustering challenges posed by low-frequency mutations, inferring the
relationships of the resulting low prevalence clusters is also problematic as the evolutionary
constraints defined by sum- and crossing-rule are unlikely to define a unique phylogeny. An
example for this is the low-frequency cluster inferred by PyClone in the TS data, which
contains 29 mutations (pink cluster in Figure 4.15). Based on the cellular prevalence
estimates shown in Figure 4.14, several tree topologies are possible. In fact, the cluster could
be downstream of any of the other clusters. Even though LICHeE can in principle infer
multiple compatible trees, LICHeE only generated a single tree in this case and concluded
that the low-frequency cluster lies downstream of the cluster containing ten mutations. For
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some of the mutations in this cluster, this is a clear contradiction of the observed mutation
patterns.
Together, the challenges of clustering and phylogeny inference of low-frequency muta-
tions indicate that a higher filtering threshold for PyClone clusters should be used during
the analysis to infer reliable phylogenies. This would further reduce the number of assigned
variants. Treeomics and OncoNEM can infer phylogenies with higher resolution in this case,
but their ability to detect subclone mixing is limited or non-existent. Furthermore, their
performance may be worse for samples with more mixed subpopulations, as explained in
Chapter 2.
4.2.3.4 Conclusions of method comparison
Assignment of mutations One important motivation for inferring trees is to assess
which mutations are shared by different populations in the tumour. Throughout the LICHeE
analysis pipeline, a large proportion of mutations is lost, limiting the ability to characterise
the subpopulations in the tumour. In our study, this problem is even more pronounced for
SuperFreq, which excludes private mutations and many of the mutations in regions of copy
number aberrations. On average, the fraction of the genome affected by CNAs is larger in
breast cancer than in many other cancers [124]. Therefore, SuperFreq may be better suited to
analyse SNVs in other types of cancer. Treeomics and OncoNEM assign most of the variants
to branches in the tree.
Mutation clusters An advantage of OncoNEM and Treeomics, is that they infer the tree
structure and mutation clusters simultaneously. Mutation clusters inferred by these methods
seem to be more reliable than those inferred by LICHeE and SuperFreq. This particularly
concerns low prevalence and private mutations. Stronger filtering thresholds could reduce
the number of spurious clusters but also reduce resolution. Reliability of mutation clusters
inferred by MEDICC could not be assessed.
Resolution In general, OncoNEM and Treeomics infer very similar trees, however, the
smaller branches within the major subpopulations are often not reproducible. A disadvantage
of Treeomics is its limited ability to analyse data sets containing many samples. Even though
MEDICC infers trees from copy number data, the results agree well with those of OncoNEM
and Treeomics. At the same time, MEDICC is very sensitive to changes in the copy number
fits, which shows that MEDICC does not handle noise well. LICHeE and SuperFreq infer
trees of lower resolution, often clustering samples together that can be reliably distinguished
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by the sample tree methods. Overall, LICHeE results seem to agree better with the other
methods than those of SuperFreq.
As expected, the reliability of sample tree inference suffers if samples are a mixture of
populations from different parts of the tree. Given that metastasis formation is an evolu-
tionary bottleneck, metastases are likely to be more homogeneous than primary tumours.
Performance of sample tree methods is likely to be worse for multi-sample data of primary
tumours or for tumours with more cross-seeding between metastases.
Mixing of subpopulations An advantage of Treeomics over OncoNEM is the inference
of mixed subpopulations. In practice, however, Treeomics did not identify mixtures of
subpopulations in any of the cases from WES data. Using TS data, it was able to identify
mixed populations in some of the cases. SuperFreq which can only be applied to WES
data identified mixed populations in few cases. Overall, LICHeE is the most sensitive
method, detecting mixing events in both WES and TS data. However, the specificity of the
subpopulation detection could not be assessed due to the lack of a ground truth.
Usability The MEDICC analysis is the most labour intensive because ploidy estimates
need to be curated manually. This makes MEDICC difficult to apply for inexperienced users.
Furthermore, manual ploidy selection can introduce biases in the analysis.
PyClone also requires copy number profiles as input. However, it appears to be less
sensitive to errors in the ploidy estimates than MEDICC and yields good results even if ploidy
values have not been manually adjusted. In our study, LICHeE required extensive filtering
of the PyClone input clusters. Without this, LICHeE ignored many of input clusters due to
incompatibilities between clusters. Even though LICHeE offers the possibility to cluster
mutations itself, it cannot adjust for copy number changes. We were unable to produce trees
that resembled those of any of the other methods by clustering VAFs using LICHeE (data not
shown). This could be different for samples with fewer CNAs.
SuperFreq is easy to use because almost all of the data pre-processing steps are imple-
mented within its pipeline. At the same time, it offers no options to optimise the pipeline
for a given data set and does not provide options for manual interventions. Even though
SuperFreq infers subset relationships between mutation clusters, it only produces fish plots,
whereas trees need to be generated by the user.
OncoNEM and Treeomics are both easy to use, working well with default parameters.
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4.2.4 Summary
In summary, all methods have different advantages and disadvantages. The choice of method
depends on the data available, the type of cancer that is being analysed and the biological
question. Using multiple methods helps to identify stable regions of trees, to robustly assign
mutations and to increase confidence in inferred mixing events.
Chapter 5
Summary and outlook
Over the past decade, cancer genome studies have generated large quantities of sequencing
data. Novel computational tools are essential to analyse this data. In particular, the aim of
inferring life histories of tumours poses novel challenges to computational biology. This
dissertation presents methods and analyses that address multiple challenges in the field of
tumour phylogenetics:
1. Single nucleotide variants obtained through single-cell DNA sequencing are noisy
and classic phylogenetic methods are not suitable to analyse this kind of data. In
Chapter 3, I develop a Bayesian scoring function to evaluate the fit between a tree
hypothesis and observed mutation data. I present an efficient heuristic search algorithm
and demonstrate the applicability of our approach in two case studies.
2. While statistical methods can be used to infer phylogenies from noisy data, the quality
of phylogenetic analysis also depends on the quality of the input data. In the first part
of Chapter 4, I describe a novel approach for the joint segmentation of copy number
profiles of multiple related samples and demonstrate its advantages in two case studies.
3. A plethora of methods exist for the inference of tumour phylogenies from bulk sequenc-
ing data of multiple samples. An extensive comparison of these methods is lacking,
and no best practice guide exists. In the second part of Chapter 4, I demonstrate how
multiple, conceptually different methods can be used in a comprehensive phylogenetic
analysis to assess the reliability of the inferred results.
In summary, this thesis contributes important methodology to the field of tumour phy-
logenetics and demonstrates the usefulness of multi-sample bulk sequencing approaches
developed by others. It thereby highlights significant advances that have been made over
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the past few years. Nevertheless, challenges and opportunities in different parts of the field
remain to be addressed.
Phylogenetic methods for single-cell copy number data Copy number alterations
can affect overlapping regions of the genome, which means that copy number data usually
contains horizontal dependencies [151]. Therefore, OncoNEM and similar methods are un-
suitable to infer phylogenies from this type of data. MEDICC, in turn, is not computationally
efficient enough to analyse large numbers of cells and does not take into account noise in the
data. Future single-cell inference approaches could use copy number information on its own
or in combination with SNVs to analyse the phylogenies of copy number driven tumours.
Combining phylogenies and gene expression phenotypes Recent advances have
enabled researchers to sequence both the genome and the transcriptome of a single cell
[28, 92]. Combining single-cell phylogenies with single-cell transcriptomics will allow
researchers to gain insights into how gene expression changes as tumours evolve.
Tumour evolution in the tissue context Cancers develop in a complex microenviron-
ment, and it has been shown that interactions between tumour and stromal cells can promote
the growth of primary tumours as well as the dissemination to other organs [90, 72]. Despite
the evidence that the microenvironment plays a role in tumour evolution, most phylogenetic
studies ignore the tissue context of samples. The most commonly used methods for single-
cell isolation require tissue disaggregation, leading to a loss of information about the spatial
origin of cells. Single-cell isolation techniques such as laser-capture microdissection, in
contrast, offer the opportunity to analyse the genome as well as the spatial tissue context of a
cell [153]. In future, this could enable researchers to study the connection between tumour
evolution and the tumour microenvironment at a higher resolution.
Best practice guide for tumour phylogenetics More and more cancer studies that per-
form genome sequencing incorporate phylogenies in their analyses. This thesis demonstrates
that a wide variety of phylogenetic methods have been developed for this purpose. However,
few researchers beyond the method development community make use of these methods.
Instead, many studies resort to unsuitable classic phylogenetic methods or manual inference.
Zhao et al. [178], for example, used multiple classic phylogenetic methods for their analysis
of SNVs but did not choose any methods developed for the inference of cancer evolution.
Similarly, Jiménez-Sánchez et al. [69] used a parsimony method to infer phylogenies from
SNVs. Joung et al. [71] also use a parsimony method but applied it to copy number data. Like
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many bulk sequencing-based methods, Yates et al. [172] used a Dirichlet process mixture
model to infer mutation clusters, but trees were inferred manually instead of using one of
the automated approaches available. All of these studies were published within the last two
years. Explanations as to why methods are not being used more widely could be a lack of
visibility of methods beyond the method development community or a lack of trust in the
methods. Alternatively, users might be overwhelmed by the number of options available
and differences between methods may not be obvious to users outside the field. A best
practice user guide could help to alleviate this problem. It could contain analyses like the
ones described in Chapter 4 but should comprise a more comprehensive set of methods.
Going beyond tree inference As tumour phylogenetics is coming of age, tumour life
histories can be inferred with reasonable confidence. While there is still room for improve-
ment on the side of inference algorithms, the biggest challenge ahead lies in the interpretation
of the inferred phylogenies. So far, inference algorithms are used to observe individual
evolutionary trajectories that happened in the past. While this may be interesting from a basic
science point of view, individual phylogenies are of limited use because they do not allow us
to distinguish features of the tree that are important for the development and progression of
the tumour from those that are not. Therefore, an important question for the future of the
field will be if and how inferred phylogenies from many patients can be combined to further
our understanding of cancer biology and to improve treatment strategies for future patients.
The holy grail would be to use tumour phylogenies of previous cases to predict the next
evolutionary steps of new tumours [62]. This goal, however, is still far out of reach and many
intermediary questions need to be answered first. For example, one question regarding the
practicability of this approach is how one can aggregate the phylogenetic information across
cases.
Matsui et al. [101] made a step in this direction by developing PhyC, an algorithm that
clusters phylogenetic trees according to their shape. While the shape of the tree might
be predictive of survival, as Matsui et al. suggest, other approaches are likely to be more
informative for predicting tumour progression pathways. An alternative approach could,
therefore, be to analyse phylogenies on a more functional level, for example, by aggregating
information from the phylogenetic trees on the basis of mutated genes or pathways. This
poses a challenging project in itself, as it is currently unclear if and how this could be done.
Even if we achieve to summarise the information gained from phylogenetic trees, many
important questions remain unanswered: How do parameters such as the number of samples
and the spatial distribution of the samples taken influence the resolution of the tree, its shape
and ultimately the aggregated results? How many cases are needed and how detailed do the
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phylogenetic trees need to be in order to achieve robust results? Most importantly, is the
aggregated result informative? What can we learn from it? Can we discover reoccurring
patterns of mutated pathways? How can we use all of this to make predictions?
All these questions show that there is a long way to go before these approaches can
have an impact on real lives. Instead of focusing on incremental improvements by further
optimising phylogenetic inference algorithms, it is crucial to approach the next steps that
go beyond tree inference in order to ensure that tumour phylogenetics will lead to more
than singular observations. This does not imply that further technical improvements of
phylogenetic algorithms will be unnecessary. However, further optimisations of phylogenetic
algorithms should be guided by the requirements of the aggregation methods that are yet to be
developed. In any case, without progress which brings us closer to summarising phylogenetic
information across cases to generate robust biological conclusions, the information gained
through tumour phylogenetics cannot be used to its full potential.
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Fig. A.1 Dependence of oncoNEM on inference parameters. This second example uses a
much lower FPR of 10−5 and shows again that (i) oncoNEM estimates error parameters
that are close to the ground truth parameters and (ii) oncoNEM is robust to changes in
those parameters. The left panel shows the log Bayes factor of the highest scoring model
inferred with the respective parameter combination relative to highest scoring model overall.
The second and the third panels show that a large range of parameter combinations around
the ground truth parameters yield solutions close to the ground truth tree in terms of
pairwise cell shortest-path distance and V-measure. The distance was normalised to the
largest distance observed between any inferred tree and the ground truth.
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Fig. A.2 Trees inferred with estimated parameters (middle tree) and parameters that are
similar to the estimated ones (outer trees) for data set by Li et al. [85]. Even if the inference
parameters are varied, the overall structure and features of the oncoNEM tree are preserved.
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Fig. A.3 OncoNEM solution based on a subset of the mutations in the bladder cancer
data set. For this analysis all mutations within regions affected by loss of heterozygosity
were excluded from the data set. Genomic regions of the bladder cancer affected by loss of
heterozygosity are shown in Table S1. Panel A shows the likelihood landscape with the
inferred error parameters (FPR = 0.185, FNR = 0.115), which is close to the parameters
estimated for the full data set. Panel B shows the inferred tree. As for the complete data
set, the result suggests that initially the tumour underwent a linear evolution and then
branched into two major subpopulations and some smaller ones.
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Fig. A.4 Trees inferred with estimated parameters (middle tree) and parameters that are
similar to the estimated ones (outer trees) for data set by Hou et al. [58]. Even if the
inference parameters are varied, the overall structure and features of the oncoNEM tree are
preserved.
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Table A.1 This table summarises all large genomic regions of the bladder cancer that
are affected by loss of heterozygosity as shown in Figure S5 of Li et al. [85]. To assess
the effect of loss of heterozygosity on the oncoNEM result, the onoNEM inference was
repeated on a subset of the original mutation data containing only SNVs that lie outside
these regions.
Chr Region Position (bp)
2 q33.3 - q37.3 >205 600 000
9 entire chromosome
10 q25.3 - q26.3 >114 900 000
11 p <52 900 000
22 q >11 800 000
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Fig. A.5 Tree inference from WES and sWGS data for case 308.
